Amedeo Smart

Free Medical Literature Service

 

Amedeo

Otorhinolaryngology
  Free Subscription

Articles published in
Head Neck
    May 2024
  1. DONG YJ, Zhang HH, Liang JQ, Gao YY, et al
    Laryngeal paraganglioma: The analysis of misdiagnosed cases and literature review.
    Head Neck. 2024;46:1234-1247.
    >> Share

  2. HONG SA, Armstrong AT, Snow K, Walker RJ, et al
    Association of adjuvant radiation and survival in human papilloma virus-positive oropharynx squamous cell carcinoma with lymphovascular invasion as the sole adverse pathologic feature.
    Head Neck. 2024;46:1043-1050.
    >> Share

  3. WISTERMAYER PR, Brown AE, Cave TB, Chang BA, et al
    Effect of palatine tonsil tumor resection on postoperative velopharyngeal insufficiency in transoral surgery.
    Head Neck. 2024;46:1178-1188.
    >> Share

  4. TABARI A, Nasirmohtaram S, Mohammadi HR, Zeinalizadeh M, et al
    Anterior endoscopic sublabial transmaxillary access to middle cranial base lesions.
    Head Neck. 2024;46:1028-1042.
    >> Share

  5. MATSUMURA S, Sato T, Matsushima S, Kokubu T, et al
    Retropharyngeal abscess due to Fusobacterium necrophorum complicated by progressive internal carotid artery stenosis and multiple cranial nerve palsies.
    Head Neck. 2024;46:E57-E60.
    >> Share

  6. GAIFFE O, Mahdjoub J, Ramasso E, Mauvais O, et al
    Discrimination of vocal folds lesions by multiclass classification using autofluorescence spectroscopy: An ex vivo study.
    Head Neck. 2024;46:1136-1145.
    >> Share

  7. ZHANG FG, Ow TJ, Lin J, Smith RV, et al
    Complications related to thyroidectomy among patients with hyperthyroidism: Exploring the potential for ambulatory surgery.
    Head Neck. 2024;46:1094-1102.
    >> Share

    April 2024
  8. LIEM X, de Baere T, Vivar OI, Seiwert TY, et al
    International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers.
    Head Neck. 2024 Apr 10. doi: 10.1002/hed.27739.
    >> Share

  9. BECKER AS, Merkel J, Bozkurt I, Struder DF, et al
    p16 overexpression identifies oncogenic high-risk HPV infection in non-oropharyngeal squamous cell carcinoma of the head and neck.
    Head Neck. 2024 Apr 9. doi: 10.1002/hed.27764.
    >> Share

  10. LI Y, Guan X, Xing X, Hu C, et al
    Survival outcomes and toxicity profiles among patients with nonmetastatic nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT) versus IMRT + carbon-ion radiotherapy: A propensity score-matched analysis.
    Head Neck. 2024 Apr 9. doi: 10.1002/hed.27771.
    >> Share

  11. WANG R, Manon V, Huang AT
    Perforator-based chimeric ulnar forearm microvascular free tissue transfer reconstruction of post-radiated tracheoesophageal puncture fistulae.
    Head Neck. 2024;46:973-978.
    >> Share

  12. ARAUJO AV, Wax MK, Clayburgh DR, Andersen PE, et al
    Acute and definitive management of oropharyngeal hemorrhage in patients with squamous cell carcinoma of the oropharynx.
    Head Neck. 2024;46:896-904.
    >> Share

  13. NICOLAU-NETO P, Peryassu BC, de Carvalho FN, Souza-Santos PT, et al
    ALCAM is a biomarker of tumor aggressiveness and worse prognosis in glottic laryngeal squamous cell carcinoma.
    Head Neck. 2024;46:785-796.
    >> Share

  14. JUESAS IGLESIAS L, Sanchez-Canteli M, Pedregal Mallo D, Otero-Rosales M, et al
    Prognostic value of preoperative inflammatory ratios in early glottic cancer treated with transoral laser surgery.
    Head Neck. 2024;46:819-830.
    >> Share

  15. CHABRILLAC E, Baudel L, Vergez S, Woisard V, et al
    Videofluoroscopic swallowing study to detect pharyngeal leak after total (pharyngo-) laryngectomy: Retrospective assessment of a single-institution protocol.
    Head Neck. 2024;46:740-748.
    >> Share

    March 2024
  16. LUO C, Huang W, Li S, Li H, et al
    Optimal cut-off value for identifying objective response in patients with nasopharyngeal carcinoma after induction chemotherapy.
    Head Neck. 2024 Mar 28. doi: 10.1002/hed.27754.
    >> Share

  17. KJEMS J, Lilja-Fischer JK, Friborg J, Tramm T, et al
    Separating distant recurrences from second primaries in head and neck squamous cell carcinomas - A DAHANCA group analysis on paired tumor samples.
    Head Neck. 2024 Mar 25. doi: 10.1002/hed.27750.
    >> Share

  18. SAHA S, Mallick I, Mukherjee P, Chakraborty S, et al
    Are oral cancers effectively palliated with radiotherapy? Outcomes of treatment with a modified QUAD SHOT regimen.
    Head Neck. 2024 Mar 25. doi: 10.1002/hed.27730.
    >> Share

  19. MALIK NH, Montero M, Chen JJ, Sinha S, et al
    Higher area deprivation index is associated with poorer local control and overall survival in non-metastatic nasopharyngeal carcinoma.
    Head Neck. 2024 Mar 22. doi: 10.1002/hed.27751.
    >> Share

  20. BAUMAN JE, Karam SD, O'Brien C, Mak G, et al
    Durvalumab in combination with chemoradiotherapy in patients with head and neck squamous cell carcinoma: Results from the Phase 1 CLOVER study.
    Head Neck. 2024 Mar 17. doi: 10.1002/hed.27726.
    >> Share

  21. SNYDER V, Smith B, Kim S, Spector ME, et al
    Evaluation of the safety and effectiveness of robot-assisted neck dissections.
    Head Neck. 2024 Mar 15. doi: 10.1002/hed.27731.
    >> Share

  22. GILJA S, Vasan V, Kumar A, Roof SA, et al
    Treatment discordance in the utilization of neck dissection for stage I-II supraglottic tumors.
    Head Neck. 2024 Mar 14. doi: 10.1002/hed.27736.
    >> Share

  23. ALTAWIL M, Stanisz I, Van Den Berg NH, Sheahan P, et al
    Pattern of regional recurrence after selective neck dissection for clinically positive neck in mucosal squamous carcinoma.
    Head Neck. 2024 Mar 13. doi: 10.1002/hed.27727.
    >> Share

  24. PACE GM, Morales-Olavarria C, Costantino A, Festa BM, et al
    Survival and complications after carotid resection for head and neck squamous cell carcinoma: A systematic review and pooled analysis.
    Head Neck. 2024 Mar 12. doi: 10.1002/hed.27723.
    >> Share

  25. TABAKSERT A, James T, Rusius C, Walters H, et al
    Drainless, day-case lateral neck dissection with Artiss fibrin sealant: A prospective cohort study.
    Head Neck. 2024 Mar 11. doi: 10.1002/hed.27715.
    >> Share

  26. MIKHAEL M, Kansara B, Basta A, Hume E, et al
    Optimizing presurgical education for patients with head and neck cancer receiving laryngectomy and free flap surgery: A qualitative study.
    Head Neck. 2024 Mar 9. doi: 10.1002/hed.27729.
    >> Share

  27. KANSAL V, Kinney BLC, Schmitt NC
    Characterization of the tumor microenvironment in the mouse oral cancer (MOC1) model after orthotopic implantation in the buccal mucosa.
    Head Neck. 2024 Mar 6. doi: 10.1002/hed.27722.
    >> Share

  28. ZHANG Y, Wang Y, Zhu Y, Wan H, et al
    Diagnostic value of water swallow test for dysphagia in patients with head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2024 Mar 6. doi: 10.1002/hed.27713.
    >> Share

  29. SREEJEEV AT, Joseph D, Krishnan AS, Pasricha R, et al
    Weekly assessment of volumetric and dosimetric changes during volumetric modulated arc therapy of locally advanced head and neck carcinoma: Implications for adaptive radiation therapy-A prospective study.
    Head Neck. 2024 Mar 4. doi: 10.1002/hed.27710.
    >> Share

  30. LU C, Yang Y, Zhang M, Li J, et al
    Establishment of an in situ model to explore the tumor immune microenvironment in head and neck squamous cell carcinoma.
    Head Neck. 2024 Mar 4. doi: 10.1002/hed.27707.
    >> Share

  31. JOHNS JD, Choe EJ, Chisolm PF, Pothast MJ, et al
    The impact of COVID-19 and vaccination status on outcomes in veterans with head and neck squamous cell carcinoma.
    Head Neck. 2024 Mar 3. doi: 10.1002/hed.27714.
    >> Share

  32. MELIANTE PG, Battilocchi L, Costantino A, Lee K, et al
    Transoral robotic vertical partial laryngectomy (hemilaryngectomy) extended to the hypopharynx.
    Head Neck. 2024;46:708-712.
    >> Share

  33. STRADLING EJ, Barnhart MK, Robinson RA, Mogg PJ, et al
    Implementing flexible endoscopic evaluation of swallow screening within annual cancer surveillance appointments to monitor for late-stage radiation-induced dysphagia: A feasibility study.
    Head Neck. 2024;46:615-626.
    >> Share

  34. MITRA S, Panda S, Thakar A, Gautam V, et al
    Quality of life and swallowing outcomes following major glossectomy: A prospective single-center experience.
    Head Neck. 2024;46:599-608.
    >> Share

  35. HANSEN NJ, Woodman K, Buoy S, Mao S, et al
    Tongue electrical impedance myography correlates with functional, neurophysiologic, and clinical outcome measures in long-term oropharyngeal cancer survivors with and without hypoglossal neuropathy: An exploratory study.
    Head Neck. 2024;46:581-591.
    >> Share

  36. WU C, Yan X, Xie F, Lai X, et al
    Development of a nomogram for predicting pharyngocutaneous fistula based on skeletal muscle mass and systemic inflammation indices.
    Head Neck. 2024;46:571-580.
    >> Share

  37. DIVAKAR P, Kim SS, Kerr DA, Pettus JR, et al
    The art of specimen orientation: Two-dimensional maps for oropharynx squamous cell carcinoma.
    Head Neck. 2024;46:702-707.
    >> Share

  38. YUVNIK T, Chia L, Laura OC, Tieu TT, et al
    Differences in geometric patterns of failure in human papillomavirus (HPV)-associated and HPV-non-associated oropharyngeal cancer after definitive radiotherapy.
    Head Neck. 2024;46:552-560.
    >> Share

  39. LAXAGUE F, Zeng PYF, Zabihi D, Fnais N, et al
    A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV- patients undergoing chemoradiation for oropharyngeal squamous cell carcinomas.
    Head Neck. 2024;46:503-512.
    >> Share

  40. MAO S, Tang R, Gu Y, Chen B, et al
    Endoscopic endonasal combined transoral medial approach to the nasopharynx, parapharyngeal space, and jugular foramen.
    Head Neck. 2024;46:485-491.
    >> Share

  41. BARCZYNSKI M, Konturek A
    Clinical validation of NerveTrend versus conventional i-IONM mode of NIM Vital in prevention of recurrent laryngeal nerve events during bilateral thyroid surgery: A randomized controlled trial.
    Head Neck. 2024;46:492-502.
    >> Share

  42. FUOCO J, Huang M, Esfandiari N, MacMillan C, et al
    SMARCB1 (INI1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two cases.
    Head Neck. 2024;46:E32-E39.
    >> Share

    February 2024
  43. LEE JJ, Rapoport NA, Pipkorn P, Puram SV, et al
    Airway protection and outcomes after staged versus concurrent bilateral neck dissections with transoral base of tongue cancer resection.
    Head Neck. 2024 Feb 27. doi: 10.1002/hed.27696.
    >> Share

  44. KONO M, Wakisaka R, Komatsuda H, Hayashi R, et al
    Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancer.
    Head Neck. 2024 Feb 23. doi: 10.1002/hed.27703.
    >> Share

  45. LU HJ, Hsieh MC, Wang HM, Hsieh JC, et al
    Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society registry database.
    Head Neck. 2024 Feb 22. doi: 10.1002/hed.27681.
    >> Share

  46. QI Y, Shao W, Gao J, Ni N, et al
    Monoamine oxidase B inhibits epithelial-mesenchymal transition and trigger apoptosis via targeting ERK1/2 signaling pathway in head and neck squamous cell carcinoma.
    Head Neck. 2024 Feb 20. doi: 10.1002/hed.27697.
    >> Share

  47. JIN YN, Xiao ZW, Yao W, Yu J, et al
    Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in elderly patients with stage III-IVa nasopharyngeal carcinoma: A real-world study based on medical comorbidities.
    Head Neck. 2024 Feb 17. doi: 10.1002/hed.27689.
    >> Share

  48. ZHU KX, Ding T, E YM, Yang HW, et al
    Effect of waiting time for radiotherapy after last induction chemotherapy on prognosis of locally advanced nasopharyngeal carcinoma.
    Head Neck. 2024 Feb 17. doi: 10.1002/hed.27680.
    >> Share

  49. MANDUCHI B, Che Z, Ringash JG, Fitch MI, et al
    Patient-reported outcome measures for dysphagia in head and neck cancer: A systematic review and appraisal of content validity and internal structure.
    Head Neck. 2024 Feb 15. doi: 10.1002/hed.27693.
    >> Share

  50. HOLLENBEAK CS, Duan F, Subramaniam RM, Taurone A, et al
    Quality of life following surgery for head and neck cancer: Evidence from ACRIN 6685.
    Head Neck. 2024 Feb 14. doi: 10.1002/hed.27673.
    >> Share

  51. MASCARELLA MA, Ferdus J, Vendra V, Sridharan S, et al
    Sarcopenia predicts short-term treatment-related toxicity in patients undergoing curative-intent therapy for head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2024 Feb 14. doi: 10.1002/hed.27688.
    >> Share

  52. MORIMOTO H, Tsujikawa T, Miyagawa-Hayashino A, Kimura A, et al
    Neutrophil-to-lymphocyte ratio associates with nutritional parameters, intratumoral immune profiles, and clinical outcomes of pembrolizumab in head and neck squamous cell carcinoma.
    Head Neck. 2024 Feb 12. doi: 10.1002/hed.27671.
    >> Share

  53. JIAM ML, Xin KZ, Ha PK, Jiam NT, et al
    A supervised machine learning model for identifying predictive factors for recommending head and neck cancer surgery.
    Head Neck. 2024 Feb 12. doi: 10.1002/hed.27674.
    >> Share

  54. WANG CC, Hsu MH, Lee CT, Chen CJ, et al
    Prognostic significances of systemic inflammatory response markers in patients with synchronous esophageal and head and neck cancers.
    Head Neck. 2024 Feb 12. doi: 10.1002/hed.27677.
    >> Share

  55. MONAGHAN NP, Duckett KA, Nguyen SA, Newman JG, et al
    Vascular events in patients with head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2024 Feb 9. doi: 10.1002/hed.27675.
    >> Share

  56. MA L, Lan F, Chen P, Lei L, et al
    Loco-regional radiotherapy in de novo metastatic nasopharyngeal carcinoma with chemotherapy and immunotherapy: A real-world retrospective study from two cancer centers.
    Head Neck. 2024 Feb 5. doi: 10.1002/hed.27665.
    >> Share

  57. BENAIGES E, Ceperuelo-Mallafre V, Guaita S, Maymo-Masip E, et al
    Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma.
    Head Neck. 2024 Feb 2. doi: 10.1002/hed.27651.
    >> Share

  58. OMURA K, Nomura K, Aoki S, Takeda T, et al
    Simple and safe resection of the crista galli.
    Head Neck. 2024;46:439-446.
    >> Share

  59. GALLI J, Perna L, Rossi G, Corina L, et al
    Hybrid primary puncture in stapler-assisted total laryngectomy.
    Head Neck. 2024;46:435-438.
    >> Share

  60. ARIIZUMI Y, Hanai N, Asakage T, Seto A, et al
    Extent of thyroidectomy and paratracheal lymph node dissection in total pharyngolaryngectomy for pyriform sinus cancer, and recurrence, survival, and postoperative hypoparathyroidism: A multicenter retrospective study.
    Head Neck. 2024;46:269-281.
    >> Share

  61. BANYI N, Kwon JJY, Turkdogan S, Milner TD, et al
    Incidence and complications of hypothyroidism postlaryngectomy: A systematic review and meta-analysis.
    Head Neck. 2024;46:249-261.
    >> Share

  62. TOMIZAWA K, Motegi A, Oyoshi H, Fujisawa T, et al
    Accelerated three-dimensional conformal radiotherapy for early-stage glottic cancer in reducing dose to the internal carotid artery and pharyngeal constrictor muscles.
    Head Neck. 2024;46:239-248.
    >> Share

    January 2024
  63. LI L, Fan L, Jiang Z, Yang X, et al
    Pedicled flaps reconstruction of hypopharynx and laryngeal defects: Successful preservation of laryngeal function in patients with advanced hypopharyngeal cancer.
    Head Neck. 2024 Jan 26. doi: 10.1002/hed.27650.
    >> Share

  64. YANG Z, Mansour J, Sun P, Wei P, et al
    Impact of pretreatment body mass index on the survival of head and neck cancer patients.
    Head Neck. 2024 Jan 25. doi: 10.1002/hed.27659.
    >> Share

  65. ASCHEN SZ, O'Connell GM, Kutler DI, Spector JA, et al
    Financial (dis)incentives to surgical management of head and neck cancer care.
    Head Neck. 2024 Jan 24. doi: 10.1002/hed.27649.
    >> Share

  66. SHEN B, Zhou Y, Wu D, Liu J, et al
    Efficacy of photobiomodulation therapy in the management of oral mucositis in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials.
    Head Neck. 2024 Jan 24. doi: 10.1002/hed.27655.
    >> Share

  67. KU PKM, Vlantis AC, Hui TSC, Yeung ZWC, et al
    The prevalence of gastroesophageal reflux disease and laryngopharyngeal reflux in patients with dysphagia after radiotherapy for nasopharyngeal carcinoma.
    Head Neck. 2024 Jan 18. doi: 10.1002/hed.27645.
    >> Share

  68. MATOBA T, Minohara K, Kawakita D, Sawabe M, et al
    Impact of salvage chemotherapy after immune checkpoint inhibitor for recurrent or metastatic head and neck cancer.
    Head Neck. 2024 Jan 16. doi: 10.1002/hed.27643.
    >> Share

  69. SASSANO M, Taborelli M, Boccia S, Cadoni G, et al
    Aspirin intake and head and neck cancer: A pooled analysis within the INHANCE consortium.
    Head Neck. 2024 Jan 16. doi: 10.1002/hed.27638.
    >> Share

  70. WEI J, Su J, Wang J, Jia X, et al
    An open, multicenter, exploratory study of apatinib mesylate maintenance therapy for recurrent/metastatic head and neck squamous cell carcinoma (ChiCTR1800019375).
    Head Neck. 2024 Jan 14. doi: 10.1002/hed.27636.
    >> Share

  71. VENCHIARUTTI RL, Clark JR AM, Palme CE, Dwyer P, et al
    Associations between patient-level health literacy and diagnostic time intervals for head and neck cancer: A prospective cohort study.
    Head Neck. 2024 Jan 11. doi: 10.1002/hed.27633.
    >> Share

  72. CHIEN IA, Hsu YC, Tsai CH, Cheng SP, et al
    Population-based analysis of the human development index and risk factors for head and neck cancer.
    Head Neck. 2024 Jan 11. doi: 10.1002/hed.27639.
    >> Share

  73. MANDUCHI B, Fitch MI, Ringash JG, Howell D, et al
    A core outcome set for patient-reported dysphagia for use in head and neck cancer clinical trials: An international multistakeholder Delphi study.
    Head Neck. 2024 Jan 10. doi: 10.1002/hed.27626.
    >> Share

  74. TALANI C, Astradsson T, Farnebo L, Makitie A, et al
    Pretreatment fat-free mass index correlates with early death in patients with head and neck squamous cell carcinoma.
    Head Neck. 2024 Jan 9. doi: 10.1002/hed.27628.
    >> Share

  75. BERG M, Hansson C, Silander E, Bove M, et al
    A randomized study comparing the nutritional effects of radiotherapy with cetuximab versus cisplatin in patients with advanced head and neck cancer.
    Head Neck. 2024 Jan 8. doi: 10.1002/hed.27619.
    >> Share

  76. HUANG N, He Q, Yang Y, Wang X, et al
    Clinical characteristics and prognostic factors in nasopharyngeal carcinoma with brain metastasis: A retrospective, single-center study.
    Head Neck. 2024 Jan 5. doi: 10.1002/hed.27625.
    >> Share

  77. GISSI DB, Rossi R, Lenzi J, Tarsitano A, et al
    Thirteen-gene DNA methylation analysis of oral brushing samples: A potential surveillance tool for periodic monitoring of treated patients with oral cancer.
    Head Neck. 2024 Jan 3. doi: 10.1002/hed.27621.
    >> Share

  78. OGAWA T, Ono K, Ryumon S, Kawai H, et al
    Novel mechanism of cisplatin resistance in head and neck squamous cell carcinoma involving extracellular vesicles and a copper transporter system.
    Head Neck. 2024 Jan 2. doi: 10.1002/hed.27620.
    >> Share

  79. PATEL EJ, Strohl MP, Yom SS, El-Sayed I, et al
    Elective management of the N0 neck in maxillary sinus squamous cell carcinoma.
    Head Neck. 2024;46:171-176.
    >> Share

  80. TIRELLI G, Marcuzzo AV, Gardenal N, Tofanelli M, et al
    Prognostic role of the MRI-based involvement of superior pharyngeal constrictor muscle in oropharyngeal squamous cell carcinoma.
    Head Neck. 2024;46:161-170.
    >> Share

  81. CORTINA LE, Wu MP, Meyer CD, Feng AL, et al
    Predictors of multiple dilations and functional outcomes after total laryngectomy and laryngopharyngectomy.
    Head Neck. 2024;46:138-144.
    >> Share

  82. OBERSTE M, Bose BE, Dos Anjos Borges LG, Junca H, et al
    Effects of squamous cell carcinoma and smoking status on oropharyngeal and laryngeal microbial communities.
    Head Neck. 2024;46:145-160.
    >> Share

  83. USHIRO K, Watanabe Y, Kishimoto Y, Kawai Y, et al
    Local recurrence and metachronous multiple cancers after transoral nonrobotic surgery for pharyngeal and laryngeal squamous cell carcinoma: A retrospective multicenter study.
    Head Neck. 2024;46:118-128.
    >> Share

  84. ISSA PP, Hossam E, Cheng JH, Magazine BM, et al
    Completion thyroidectomy: A safe option for high-volume surgeons.
    Head Neck. 2024;46:57-63.
    >> Share

  85. JEROEN M, Alexander VB, Jens D, Annouschka L, et al
    Salvage total laryngectomy for squamous cell carcinoma of the larynx and hypopharynx: Validated prognostic nomograms predicting oncological outcomes.
    Head Neck. 2024;46:46-56.
    >> Share

  86. RAMESH U, Contrera KJ, Shakibai N, Su SY, et al
    Sinonasal NUT carcinoma: A consecutive case series and systematic review.
    Head Neck. 2024;46:29-36.
    >> Share

    December 2023
  87. REYES-GIBBY CC, Qdaisat A, Ferrarotto R, Fadol A, et al
    Cardiovascular events after cancer immunotherapy as oncologic emergencies: Analyses of 610 head and neck cancer patients treated with immune checkpoint inhibitors.
    Head Neck. 2023 Dec 27. doi: 10.1002/hed.27604.
    >> Share

  88. MALIK NH, Fu R, Hainc N, Noel CW, et al
    Tumor volumes in T3 supraglottic cancers treated with radiotherapy in the modern era: A study of the Canadian Head & Neck Collaborative Research Initiative.
    Head Neck. 2023 Dec 20. doi: 10.1002/hed.27608.
    >> Share

  89. LI Q, Zhu G, Zhang L, Zeng B, et al
    Mutational landscape of head and neck cancer and cervical cancer in Chinese and Western population.
    Head Neck. 2023 Dec 18. doi: 10.1002/hed.27603.
    >> Share

  90. FUJISAWA T, Motegi A, Hirata H, Zenda S, et al
    Long-term outcomes of patients with oral cavity cancer receiving postoperative radiotherapy after salvage neck dissection for cervical lymph node recurrence.
    Head Neck. 2023 Dec 18. doi: 10.1002/hed.27609.
    >> Share

  91. DA SILVA SANTOS ME, de Carvalho Abreu AK, Martins da Silva FW, Barros Ferreira E, et al
    KMT2 (MLL) family of methyltransferases in head and neck squamous cell carcinoma: A systematic review.
    Head Neck. 2023 Dec 15. doi: 10.1002/hed.27597.
    >> Share

  92. CHOI KY, Patel SD, Lane C, Tucker J, et al
    Elucidating survival and functional outcomes in patients with primary head and neck malignancies treated in academic versus community settings.
    Head Neck. 2023 Dec 12. doi: 10.1002/hed.27588.
    >> Share

  93. SAITO Y, Kobayashi K, Fukuoka O, Sakai T, et al
    Ultra-high combined positive score and high serum albumin are favorable prognostic biomarkers for immune checkpoint inhibitors in head and neck squamous cell carcinoma.
    Head Neck. 2023 Dec 8. doi: 10.1002/hed.27576.
    >> Share

  94. KIM HAJ, Zeng PYF, Cecchini M, Shaikh MH, et al
    HPV-negative head and neck cancers with adverse pathological features carry specific molecular changes that are associated with survival.
    Head Neck. 2023 Dec 7. doi: 10.1002/hed.27591.
    >> Share

  95. YOU Z, Han B, Shi Z, Zhao M, et al
    Vocal cord leukoplakia classification using deep learning models in white light and narrow band imaging endoscopy images.
    Head Neck. 2023;45:3129-3145.
    >> Share

  96. SAROUL N, Loukine M, Durand M, Pereira B, et al
    Early detection of pharyngocutaneous fistulae after total laryngectomy by cytokine in drainage: A pilot study (DEFILAC).
    Head Neck. 2023;45:3067-3074.
    >> Share

  97. PATNI A, Rastogi M, Gandhi AK, Mishra VK, et al
    Toxicities and clinical outcome of adjuvant dysphagia optimized versus standard intensity-modulated radiotherapy for post-operative oral cavity cancers: A prospective comparative study.
    Head Neck. 2023;45:3119-3128.
    >> Share

    November 2023
  98. LIU C, Cheng L, Ye W, Lin L, et al
    Risk factors for sarcopenia in patients with head and neck cancer.
    Head Neck. 2023 Nov 30. doi: 10.1002/hed.27585.
    >> Share

  99. ZANOLETTI E, Daloiso A, Nicole L, Cazzador D, et al
    Tumor budding to investigate local invasion, metastasis, and prognosis of head and neck carcinoma: A systematic review.
    Head Neck. 2023 Nov 28. doi: 10.1002/hed.27583.
    >> Share


  100. Correction to "Indications for sentinel lymph node biopsy in node-negative oral cancers".
    Head Neck. 2023 Nov 22. doi: 10.1002/hed.27577.
    >> Share

  101. DANG RR, Hu YF, Tsao CK, Young CK, et al
    Serial assessment and long-term radiographic evaluation of the maxillary sinus after inferior maxillectomy and soft tissue free flap reconstruction in patients with oral cancer.
    Head Neck. 2023 Nov 20. doi: 10.1002/hed.27575.
    >> Share

  102. ZOU X, Feng ZK, Hua YJ, Liu YP, et al
    A novel endoscopic nasopharyngectomy by low-temperature plasma radiofrequency ablation in localized recurrent nasopharyngeal carcinoma.
    Head Neck. 2023 Nov 16. doi: 10.1002/hed.27579.
    >> Share

  103. COOPER DJ, Travaglia I, Guller M, Talcott WJ, et al
    Clinical predictors of premature radiotherapy terminations in senior adults with oral cavity and laryngeal carcinoma.
    Head Neck. 2023 Nov 11. doi: 10.1002/hed.27570.
    >> Share

  104. SETHI HK, Sina EM, Mady LJ, Fundakowski CE, et al
    Sentinel lymph node biopsy for head and neck malignancies utilizing simultaneous radioisotope gamma probe and indocyanine green fluorescence navigation.
    Head Neck. 2023 Nov 7. doi: 10.1002/hed.27563.
    >> Share

  105. SU H, Li H, Hou S, Song X, et al
    Development and validation of a prognostic nomogram for patients with laryngeal cancer with synchronous or metachronous lung cancer.
    Head Neck. 2023 Nov 6. doi: 10.1002/hed.27550.
    >> Share

  106. ZOU Z, Li R, Huang X, Chen M, et al
    Identification and validation of immune-related methylated genes as diagnostic and prognostic biomarkers of nasopharyngeal carcinoma.
    Head Neck. 2023 Nov 6. doi: 10.1002/hed.27569.
    >> Share

  107. FAZELPOUR S, Vejdani-Jahromi M, Kaliaev A, Qiu E, et al
    Multiparametric machine learning algorithm for human papillomavirus status and survival prediction in oropharyngeal cancer patients.
    Head Neck. 2023;45:2882-2892.
    >> Share

  108. ROBBINS KT, Ronen O, Saba NF, Strojan P, et al
    Progress and emerging strategies to preserve function in the treatment of sinonasal cancer.
    Head Neck. 2023;45:2955-2966.
    >> Share

  109. PAOLINI F, Campo F, Iocca O, Manciocco V, et al
    It is time to improve the diagnostic workup of oropharyngeal cancer with circulating tumor HPV DNA: Systematic review and meta-analysis.
    Head Neck. 2023;45:2945-2954.
    >> Share

  110. HU Z, Guo X, Chen L, Lei W, et al
    Transnasal negative pressure therapy for accelerating healing and improving the prognosis of pharyngocutaneous fistula.
    Head Neck. 2023;45:2809-2818.
    >> Share

  111. PANUGANTI BA, Carico C, Jeyarajan H, Flagg M, et al
    Transcriptional subtypes of glottic cancer characterized by differential activation of canonical oncogenic programming.
    Head Neck. 2023;45:2851-2861.
    >> Share

    October 2023
  112. SETH I, Bulloch G, Qin KR, Xie Y, et al
    Pre-rehabilitation interventions for patients with head and neck cancers: A systematic review and meta-analysis.
    Head Neck. 2023 Oct 28. doi: 10.1002/hed.27561.
    >> Share

  113. CHECKLIN M, O'Halloran R, Foster AM, Hutchison A, et al
    The health care experiences of people with head and neck cancer: A scoping review.
    Head Neck. 2023 Oct 26. doi: 10.1002/hed.27558.
    >> Share

  114. HAN JE, Zakeri K, Michel L, Sherman EJ, et al
    Rebuttal to comment on "Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer".
    Head Neck. 2023 Oct 25. doi: 10.1002/hed.27560.
    >> Share

  115. LI X, Liu L
    Comment on "Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer".
    Head Neck. 2023 Oct 25. doi: 10.1002/hed.27559.
    >> Share

  116. LIM AE, Rogers ADG, Montgomery J
    Prospective cohort study assessing patient satisfaction and diagnostic accuracy in channeled endoscope local anesthetic biopsy in the investigation of head and neck cancer.
    Head Neck. 2023 Oct 17. doi: 10.1002/hed.27548.
    >> Share

  117. TANG YK, Xu Z, Ye ZM, Li SR, et al
    Cost-effectiveness analysis of tislelizumab in combination with chemotherapy for the first-line treatment of patients with metastatic or recurrent nasopharyngeal carcinoma in China.
    Head Neck. 2023 Oct 17. doi: 10.1002/hed.27544.
    >> Share

  118. SAITO Y, Kage H, Kobayashi K, Yoshida M, et al
    TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas.
    Head Neck. 2023 Oct 10. doi: 10.1002/hed.27540.
    >> Share

  119. ARRAZUBI V, Goni S, Gonzalez-Borja I, Hernandez-Garcia I, et al
    Circulating low density neutrophils are associated with resistance to anti-PD1 immunotherapy in squamous head and neck cancer.
    Head Neck. 2023 Oct 4. doi: 10.1002/hed.27536.
    >> Share

  120. CAI Y, Xie Y, Zhang S, Wang Y, et al
    Prediction of postoperative recurrence of oral cancer by artificial intelligence model: Multilayer perceptron.
    Head Neck. 2023 Oct 3. doi: 10.1002/hed.27533.
    >> Share

  121. SAMPIERI C, Costantino A, Giordano GG, Dale M, et al
    Predicting the need for prophylactic gastrostomy in major head and neck cancer surgery: The PEG score.
    Head Neck. 2023 Oct 3. doi: 10.1002/hed.27532.
    >> Share

  122. AGARWAL P, Bloom J, Zhou Y, Zhao R, et al
    Socioeconomic disparities in treatment and survival in patients with hypopharyngeal malignancy.
    Head Neck. 2023;45:2670-2679.
    >> Share

  123. MILINIS K, Parikh C, Williams S, Davies K, et al
    Gastrostomy dependence following pharyngolaryngectomy: The effect of preoperative tube insertion.
    Head Neck. 2023;45:2649-2656.
    >> Share

  124. BANG J, Shin HI, Kim GJ, Kim SY, et al
    Oncologic and functional outcomes of neoadjuvant chemotherapy followed by surgery in human papillomavirus-positive tonsillar cancer.
    Head Neck. 2023;45:2580-2588.
    >> Share

  125. VIANI GA, Moraes FY, Marta GN, Kowalski LP, et al
    Real-world evidence for oncological outcomes after radiotherapy or surgery for T1a-T1b glottic squamous cell carcinoma: A population-based cohort study.
    Head Neck. 2023;45:2505-2514.
    >> Share

  126. CONTRERA KJ, Phan J, Waguespack SG, Aldehaim M, et al
    Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies.
    Head Neck. 2023;45:2525-2532.
    >> Share

    September 2023
  127. BHARADIA AP, DiPalma AD
    An analysis of the correlation between safety-net hospitals and outcomes among elderly head and neck cancer patients.
    Head Neck. 2023 Sep 29. doi: 10.1002/hed.27516.
    >> Share

  128. TAJIKI S, Joya M, Gharekhani V, Richeson D, et al
    A systematic review of the normal tissue complication probability models and parameters: Head and neck cancers treated with conformal radiotherapy.
    Head Neck. 2023 Sep 28. doi: 10.1002/hed.27469.
    >> Share

  129. FARQUHAR DR, Masood MM, Lenze NR, Tasoulas J, et al
    Effect of distance of treatment center on survival for HPV-negative head and neck cancer patients.
    Head Neck. 2023 Sep 28. doi: 10.1002/hed.27522.
    >> Share

  130. ZHOU P, Zhou R, Yu YF, Rao MY, et al
    Xerostomia: An easily ignored symptom induced by induction chemotherapy in patients with nasopharyngeal carcinoma.
    Head Neck. 2023 Sep 26. doi: 10.1002/hed.27529.
    >> Share

  131. RAAD RA, Holland K, Ritz EM, Tajudeen BA, et al
    A nationwide analysis of salvage surgery for laryngeal cancer in the elderly.
    Head Neck. 2023 Sep 22. doi: 10.1002/hed.27525.
    >> Share

  132. YANG TH, Cheng YF, Chen CS, Lin HC, et al
    Increased prevalences of head and neck cancers in patients with Sjogren's syndrome.
    Head Neck. 2023 Sep 22. doi: 10.1002/hed.27518.
    >> Share

  133. GULLER M, Cooper DJ, Alkhatib H, Suru A, et al
    Impact of comorbidities on outcomes in patients with advanced head and neck cancer undergoing immunotherapy.
    Head Neck. 2023 Sep 8. doi: 10.1002/hed.27502.
    >> Share

  134. WANG Y, Wang M, Hou L, Xiang F, et al
    Incidence and risk factors of surgical site infection in patients with head and neck cancer: A meta-analysis.
    Head Neck. 2023 Sep 7. doi: 10.1002/hed.27504.
    >> Share

  135. PARK YM, Lim JY, Koh YW, Choi EC, et al
    Surgical margin status and role of adjuvant therapy in human papillomavirus-positive oropharyngeal cancer.
    Head Neck. 2023;45:2369-2376.
    >> Share

  136. SAMANIEGO C, Friedman J, Yang X, Badger C, et al
    Neoadjuvant chemotherapy enhances tumor-specific T cell immunity in patients with HPV-associated oropharyngeal cancer.
    Head Neck. 2023;45:2294-2302.
    >> Share

  137. DOUSE DM, Yin LX, Olawuni FO, Glasgow AE, et al
    Racial disparities in surgical treatment of oropharyngeal cancer: A Surveillance, Epidemiology, and End Results review.
    Head Neck. 2023;45:2313-2322.
    >> Share

  138. HAN AY, Nader ME, Lam K, Su SY, et al
    Current status of sinonasal cancer survivorship care.
    Head Neck. 2023;45:2458-2468.
    >> Share

  139. LIU Q, Lun L, Sun M, Wang Z, et al
    Feasibility of omitting contralateral neck irradiation in patients with node-negative sinonasal squamous cell carcinoma crossing the midline.
    Head Neck. 2023;45:2237-2245.
    >> Share

  140. PRASAD A, Carey RM, Panara K, Rajasekaran K, et al
    Nodal metastasis in surgically treated laryngeal squamous cell carcinoma.
    Head Neck. 2023;45:2303-2312.
    >> Share

    August 2023
  141. MCDONALD C, Kent S, Schache A, Rogers S, et al
    Health-related quality of life, functional outcomes, and complications after sentinel lymph node biopsy and elective neck dissection in early oral cancer: A systematic review.
    Head Neck. 2023 Aug 29. doi: 10.1002/hed.27495.
    >> Share

  142. SU L, Lin QJ, Ma SQ, Song XR, et al
    The effect of early oral nutritional supplements on improving nutritional outcomes and radiation-induced oral mucositis for nasopharyngeal carcinoma patients undergoing concurrent chemoradiotherapy.
    Head Neck. 2023 Aug 29. doi: 10.1002/hed.27503.
    >> Share

  143. ID SAID B, Mutsaers A, Chen H, Husain ZA, et al
    Outcomes for oligometastatic head and neck cancer treated with stereotactic body radiotherapy: Results from an international multi-institutional consortium.
    Head Neck. 2023 Aug 21. doi: 10.1002/hed.27488.
    >> Share

  144. LIN B, Lin J, Wang F, Wang Y, et al
    Computed tomography-defined sarcopenia as a risk factor for short-term postoperative complications in oral cancer patients with free flap reconstruction: A retrospective population-based cohort study.
    Head Neck. 2023 Aug 10. doi: 10.1002/hed.27479.
    >> Share

  145. LIU GY, Li Z, Chen XX, Xia WX, et al
    Effective of metastasis-directed therapy for de novo metastatic nasopharyngeal carcinoma: A propensity score matched analysis.
    Head Neck. 2023 Aug 9. doi: 10.1002/hed.27480.
    >> Share

  146. OZAWA T, Oze I, Matsuzuka T, Sasaki E, et al
    Indications for sentinel lymph node biopsy in node-negative oral cancers.
    Head Neck. 2023 Aug 8. doi: 10.1002/hed.27477.
    >> Share

  147. YUAN Y, Ye F, Wu JH, Fu XY, et al
    Early screening of nasopharyngeal carcinoma.
    Head Neck. 2023 Aug 8. doi: 10.1002/hed.27466.
    >> Share

  148. LI CX, He Q, Wang ZY, Fang C, et al
    Risk assessment of venous thromboembolism in head and neck cancer patients and its establishment of a prediction model.
    Head Neck. 2023 Aug 7. doi: 10.1002/hed.27475.
    >> Share

  149. SUNG YN, Kim Y, Cho KJ, Sim J, et al
    Assessment of thyroid cartilage ossification pattern in cancer patients: A suggestion of active ossification by tumor progression.
    Head Neck. 2023;45:2040-2046.
    >> Share

  150. VO K, Ladbury C, Tam A, Maghami E, et al
    Implications of updated staging system for p16+ oropharyngeal squamous cell carcinoma: Is valuable prognostic information being omitted?
    Head Neck. 2023;45:2079-2086.
    >> Share

  151. CHAI Y, Wei Y, Zhang D, Qi F, et al
    Comparing the role of different treatment modalities in locoregionally advanced olfactory neuroblastoma: The 20-year clinical experience of a single institution.
    Head Neck. 2023;45:1986-1999.
    >> Share

  152. LIU ZY, Khoo D, Hartel G, Punyadeera C, et al
    Post-treatment 18F-fludeoxyglocuse-positron emission tomography in human papillomavirus-associated oropharyngeal cancer.
    Head Neck. 2023;45:2000-2008.
    >> Share

  153. CHEN T, Meng ML, Hong EM, Durrant F, et al
    Effect of obesity on outcomes after open laryngeal surgery including total laryngectomy: A NSQIP database analysis.
    Head Neck. 2023;45:1913-1921.
    >> Share

    July 2023
  154. YAMADA A, Shinomiya H, Uehara N, Iritani K, et al
    Oncological outcomes of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced squamous cell carcinoma of the external auditory canal: A single-center study.
    Head Neck. 2023 Jul 28. doi: 10.1002/hed.27461.
    >> Share

  155. ZHANG MJ, Liu J, Wan SC, Li JX, et al
    CSRP2 promotes cell stemness in head and neck squamous cell carcinoma.
    Head Neck. 2023 Jul 19. doi: 10.1002/hed.27464.
    >> Share

  156. GHEDIA R, Hariri A, Lee YK, Dragan A, et al
    Saline-aided ultrasound-guided transoral biopsy of retropharyngeal nodes in head and neck cancer: A feasibility study of five patients.
    Head Neck. 2023 Jul 18. doi: 10.1002/hed.27453.
    >> Share

  157. DE FELICE F, Serpone M, Cattaneo CG, Di Giammarco F, et al
    Surgery-ineligible elderly patients with cutaneous squamous cell carcinoma of the head and neck region gain clinical benefit from definitive weekly hypofractionated radiotherapy.
    Head Neck. 2023 Jul 13. doi: 10.1002/hed.27454.
    >> Share

  158. HAN J, Zakeri K, Raab G, Hesse J, et al
    Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer.
    Head Neck. 2023 Jul 13. doi: 10.1002/hed.27456.
    >> Share

  159. HAN J, Zeng N, Tian K, Liu Z, et al
    First-line immunotherapy combinations for recurrent or metastatic nasopharyngeal carcinoma: An updated network meta-analysis and cost-effectiveness analysis.
    Head Neck. 2023 Jul 12. doi: 10.1002/hed.27452.
    >> Share

  160. LU DN, Zhang WC, Lin YZ, Zhang YN, et al
    The incidence trends of oral cancers worldwide from 1988 to 2012 and the prediction up to 2030.
    Head Neck. 2023 Jul 7. doi: 10.1002/hed.27443.
    >> Share

  161. ALBUCK AL, Issa PP, Hussein M, Aboueisha M, et al
    A combination of computed tomography scan and ultrasound provides optimal detection of cervical lymph node metastasis in papillary thyroid carcinomas: A systematic review and meta-analysis.
    Head Neck. 2023 Jul 7. doi: 10.1002/hed.27451.
    >> Share

  162. LIAN CL, Zhuo RG, Zhou R, Yu YF, et al
    Risk factors of early thyroid dysfunction after definitive radiotherapy in nasopharyngeal carcinoma patients.
    Head Neck. 2023 Jul 6. doi: 10.1002/hed.27448.
    >> Share

  163. NIERI CA, Benaim EH, Zhang YH, Garcia-Godoy F, et al
    Botox for the prevention of radiation-induced Sialadenitis and xerostomia in head and neck cancer patients: A pilot study.
    Head Neck. 2023 Jul 4. doi: 10.1002/hed.27449.
    >> Share

  164. VAN ROOIJ JAF, Roubos J, Vrancken Peeters NJMC, Rijken BFM, et al
    Long-term patient-reported outcomes after reconstructive surgery for head and neck cancer: A systematic review.
    Head Neck. 2023 Jul 4. doi: 10.1002/hed.27450.
    >> Share

  165. MENEZES FDS, Verzinhasse Peres S, de Castro Junior G, Antunes JLF, et al
    Survival inequalities in head and neck cancers: A hospital-based cohort study.
    Head Neck. 2023 Jul 4. doi: 10.1002/hed.27433.
    >> Share

  166. SOMAY E, Yilmaz B, Topkan E, Kucuk A, et al
    The predictive usefulness of the novel "combined hemoglobin-to-platelet ratio and maximum mouth opening index" on prevalence of radiation induced trismus in patients with nasopharyngeal cancer.
    Head Neck. 2023;45:1823-1831.
    >> Share

  167. BAHIG H, Ehab HY, Garden AS, Ng SP, et al
    Long-term outcomes of modern multidisciplinary management of sinonasal cancers: The M. D. Anderson experience.
    Head Neck. 2023;45:1692-1703.
    >> Share

  168. QUEIROZ GSR, Carron J, Macedo LT, Lima CSP, et al
    Influence of variants in serotonin modulating genes on the risk, aggressiveness, and prognosis of oropharynx cancer.
    Head Neck. 2023;45:1790-1800.
    >> Share

  169. KHURANA N, Babajanian E, McCrary H, Pulsipher A, et al
    Vascular permeability in HPV+ oropharyngeal cancers aids in fluorescent image-guided transoral robotic surgery using indocyanine green.
    Head Neck. 2023;45:1728-1740.
    >> Share

  170. MAVRIKIOS A, Goudjil F, Beddok A, Zefkili S, et al
    Proton therapy and/or helical tomotherapy for locally advanced sinonasal skull base adenoid cystic carcinoma: Focus on experience of the Institut Curie and review of literature.
    Head Neck. 2023;45:1619-1631.
    >> Share

    June 2023
  171. WELLENSTEIN DJ, Woodburn J, Marres HAM, van den Broek GB, et al
    Detection of laryngeal carcinoma during endoscopy using artificial intelligence.
    Head Neck. 2023 Jun 28. doi: 10.1002/hed.27441.
    >> Share

  172. NUGENT SM, Slatore CG, Winchell K, Handley R, et al
    Prevalence and correlates of high-dose opioid use among survivors of head and neck cancer.
    Head Neck. 2023 Jun 27. doi: 10.1002/hed.27432.
    >> Share

  173. PASCHEN C, Moll M, Altorjai G, Hecking M, et al
    Effect of mannitol-based reduced-volume hydration on kidney function in concomitant cisplatin-based chemoradiation for head-and-neck squamous cell carcinoma.
    Head Neck. 2023 Jun 22. doi: 10.1002/hed.27438.
    >> Share

  174. PETRUZZI G, Coden E, Iocca O, di Maio P, et al
    Machine learning in laryngeal cancer: A pilot study to predict oncological outcomes and the role of adverse features.
    Head Neck. 2023 Jun 22. doi: 10.1002/hed.27434.
    >> Share

  175. CHUNG A, Chung YT, Liang YW, Chung YL, et al
    Waldeyer ring microbiome in relation to chemoradiation-induced oral mucositis in patients with nasopharyngeal carcinoma.
    Head Neck. 2023 Jun 20. doi: 10.1002/hed.27431.
    >> Share

  176. ZHAO Z, Liao Q, Yang Y, Ma Y, et al
    Survival analysis of a comprehensive treatment strategy for internal carotid artery blowout syndrome by nasopharyngeal carcinoma.
    Head Neck. 2023 Jun 13. doi: 10.1002/hed.27393.
    >> Share

  177. TSAI MH, Chuang HC, Chien CY, Huang TL, et al
    Lymph node ratio as a survival predictor for head and neck squamous cell carcinoma with multiple adverse pathological features.
    Head Neck. 2023 Jun 9. doi: 10.1002/hed.27428.
    >> Share

  178. HUANG S, Zhan Y, Jeon S, Bruner DW, et al
    Longitudinal associations among physical activity, inflammatory markers, and quality of life in patients with head and neck cancer.
    Head Neck. 2023 Jun 8. doi: 10.1002/hed.27420.
    >> Share

  179. NAEGELE S, Efthymiou V, Hirayama S, Zhao BY, et al
    Double trouble: Synchronous and metachronous primaries confound ctHPVDNA monitoring.
    Head Neck. 2023;45:E25-E30.
    >> Share

  180. LAVIGNE D, De-Meric-de-Bellefon M, Nguyen-Tan FP, Landry D, et al
    Incidence and predictive factors of retropharyngeal lymph node metastases in patients with oropharyngeal cancer undergoing multimodality treatment planning imaging.
    Head Neck. 2023;45:1530-1538.
    >> Share

  181. MATTIOLI F, Lo Manto A, Miglio M, Serafini E, et al
    Oropharyngeal squamous cell carcinoma: Prognostic factors for development of distant metastases and oncological outcomes.
    Head Neck. 2023;45:1406-1417.
    >> Share

  182. TOMASONI M, Marazzi E, Rampinelli V, Mattavelli D, et al
    Lymph node metastasis from olfactory neuroblastoma at presentation and as disease relapse: A systematic review and proportion meta-analysis of prevalence data and variables influencing regional control.
    Head Neck. 2023;45:1486-1496.
    >> Share

  183. CAO C, Xu Y, Qiang M, Tao C, et al
    The impact of the COVID-19 pandemic on nasopharyngeal carcinoma extent at FDG PET/MR staging: The NPCOVIPET study.
    Head Neck. 2023 Jun 1. doi: 10.1002/hed.27424.
    >> Share

    May 2023
  184. TING HSL, Chen Z, Chan JYK
    Systematic review on oral microbial dysbiosis and its clinical associations with head and neck squamous cell carcinoma.
    Head Neck. 2023 May 30. doi: 10.1002/hed.27422.
    >> Share

  185. LIU X, Huang J, Qin Y, Zhang Z, et al
    Nomograms incorporating primary tumor response at mid-radiotherapy to predict survival in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2023 May 19. doi: 10.1002/hed.27404.
    >> Share

  186. KAO DD, Ferrandino RM, Roof SA, Marshall DC, et al
    Neutrophil-to-lymphocyte ratio as a predictor of surgical outcomes in head and neck cancer.
    Head Neck. 2023 May 19. doi: 10.1002/hed.27402.
    >> Share

  187. SUN K, Tan JY, Thomson PJ, Choi SW, et al
    Influence of time between surgery and adjuvant radiotherapy on prognosis for patients with head and neck squamous cell carcinoma: A systematic review.
    Head Neck. 2023 May 16. doi: 10.1002/hed.27401.
    >> Share

  188. LUAN CW, Kuo LT, Wang YT, Liao CT, et al
    Utility of modified Glasgow prognostic score for head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Head Neck. 2023 May 10. doi: 10.1002/hed.27397.
    >> Share

  189. MENG NH, Li CI, Hua CH, Lin TC, et al
    Longitudinal changes in swallowing function after surgery and proactive swallowing therapy for oral cancer.
    Head Neck. 2023 May 8. doi: 10.1002/hed.27373.
    >> Share

  190. TASHMAN K, Noyes EA, Warinner CB, Ogbonna J, et al
    The relationship between safety-net hospital status and outcomes among elderly head and neck cancer patients.
    Head Neck. 2023 May 8. doi: 10.1002/hed.27385.
    >> Share

  191. KIRTANE K, Hoogland AI, Li X, Rodriguez Y, et al
    Patient-reported outcomes in immunotherapy for head and neck cancer.
    Head Neck. 2023 May 4. doi: 10.1002/hed.27388.
    >> Share

  192. SMITH JD, Ludwig ML, Bhangale AD, Brummel C, et al
    Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16-positive oropharynx cancer.
    Head Neck. 2023;45:1281-1287.
    >> Share

  193. TAMAGAWA K, Shinomiya H, Okada T, Tatehara S, et al
    Ligation of the ethmoid arteries in superselective intra-arterial infusion of cisplatin for advanced maxillary sinus cancer fed by the ophthalmic artery.
    Head Neck. 2023;45:E16-E24.
    >> Share

  194. MAULIK S, Roy P, Mallick I, Prasath S, et al
    Definitive chemoradiation for oropharyngeal squamous carcinomas: Outcomes with intensity-modulated radiation therapy using simultaneous integrated boost, in a majorly p16 negative cohort.
    Head Neck. 2023;45:1156-1161.
    >> Share

  195. POLLOCK AE, Arons D, Alexander GS, Alicia D, et al
    Gross tumor volume margin and local control in p16-positive oropharynx cancer patients treated with intensity modulated proton therapy.
    Head Neck. 2023;45:1088-1096.
    >> Share

    April 2023
  196. LORENZ FJ, Mahase SS, Miccio J, King TS, et al
    Update on adherence to guidelines for time to initiation of postoperative radiation for head and neck squamous cell carcinoma.
    Head Neck. 2023 Apr 27. doi: 10.1002/hed.27380.
    >> Share

  197. ZHAO F, Zhu S, Fang J, Dong H, et al
    Correlation of DNA methylation and lymph node metastasis in papillary thyroid carcinoma.
    Head Neck. 2023 Apr 25. doi: 10.1002/hed.27377.
    >> Share

  198. SMITH JB, Jayanth P, Hong SA, Simpson MC, et al
    The "Medicare effect" on head and neck cancer diagnosis and survival.
    Head Neck. 2023 Apr 25. doi: 10.1002/hed.27379.
    >> Share

  199. VENCHIARUTTI RL, Charters EK, Dunn M, Clark JR, et al
    Construct and discriminant validity testing of the FACE-Q Head and Neck Cancer Module for assessing speech and swallowing outcomes for patients undergoing maxillectomy or mandibulectomy.
    Head Neck. 2023 Apr 13. doi: 10.1002/hed.27366.
    >> Share

  200. XU X, Gopinathan A, Ong YK, Thye Thong MK, et al
    Deconstructive versus reconstructive approach to internal carotid artery blowout in radiated nasopharyngeal carcinoma: A tertiary center experience and systematic review.
    Head Neck. 2023 Apr 10. doi: 10.1002/hed.27367.
    >> Share

  201. CHATTERJEE S, Kiyota N, Vaish R, Sharma A, et al
    Weekly versus 3-weekly cisplatin along with radiotherapy for locoregionally advanced non-nasopharyngeal head and neck cancers: Is the equipoise in literature addressed yet?
    Head Neck. 2023 Apr 5. doi: 10.1002/hed.27365.
    >> Share

  202. XU J, Zhu Y, Wu H, Yang C, et al
    Early swallowing intervention after free flap reconstruction for oral cancer: A systematic review and meta-analysis.
    Head Neck. 2023 Apr 3. doi: 10.1002/hed.27356.
    >> Share

  203. HANUBAL KS, Galochkina Z, Lee JH, List MA, et al
    Tumor volume as a predictor of survival in advanced laryngeal cancer treated with total laryngectomy.
    Head Neck. 2023 Apr 3. doi: 10.1002/hed.27351.
    >> Share

  204. PAPAZIAN MR, Chow MS, Jacobson AS, Tran T, et al
    Role of transoral robotic surgery in surgical treatment of early-stage supraglottic larynx carcinoma.
    Head Neck. 2023;45:972-982.
    >> Share

  205. TIKKA T, Hall MA, de Blieck SM, Buchanan MA, et al
    Swallowing outcomes following division of pseudo-epiglottis resulting from vertical pharyngeal closure in laryngectomy.
    Head Neck. 2023;45:952-962.
    >> Share

  206. LIU Q, Lun L, Sun M, Wang Z, et al
    Feasibility of ipsilateral elective neck irradiation of levels Ib and II without level III in patients with node-negative sinonasal squamous cell carcinoma.
    Head Neck. 2023;45:775-782.
    >> Share

    March 2023
  207. FENG Y, Xu T, Xu Y, Wu Z, et al
    Do all patients at the initial stage of nasopharyngeal carcinoma need bone metastasis screening? A retrospective study.
    Head Neck. 2023 Mar 28. doi: 10.1002/hed.27360.
    >> Share

  208. BENJAMIN WJ, Yalamanchi P, Taylor JMG, Lenze N, et al
    Impact of monoclonal antibody therapy for head and neck cancer on end-of-life care utilization and costs.
    Head Neck. 2023 Mar 28. doi: 10.1002/hed.27359.
    >> Share

  209. VENCHIARUTTI RL, Kapoor R, Clark JR, Palme CE, et al
    Interventions to reduce times to diagnosis and treatment of head and neck cancer: A systematic review and narrative synthesis.
    Head Neck. 2023 Mar 27. doi: 10.1002/hed.27343.
    >> Share

  210. WANG Q, Zhao Y, Chen Y, Chen Y, et al
    High PD-L1 expression associates with low T-cadherin expression and poor prognosis in human papillomavirus-negative head and neck squamous cell carcinoma.
    Head Neck. 2023 Mar 20. doi: 10.1002/hed.27329.
    >> Share

  211. KOSTECKI KL, Iida M, Wiley AL, Kimani S, et al
    Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancer.
    Head Neck. 2023 Mar 20. doi: 10.1002/hed.27340.
    >> Share

  212. SAHA P, Sawant S, Deshmukh A, Hole A, et al
    Serum Raman spectroscopy: Prognostic applications in oral cancers.
    Head Neck. 2023 Mar 15. doi: 10.1002/hed.27338.
    >> Share

  213. TUOMI L, Magnusson-Sandkvist J, Fridolfsson J, Arvidsson D, et al
    A pilot study using pre-treatment physical activity level to predict long-term health-related quality of life in patients with head and neck cancer.
    Head Neck. 2023 Mar 13. doi: 10.1002/hed.27345.
    >> Share

  214. WANG N, Lin Y, Chen F, Liu F, et al
    Utility of gamma-glutamyl transpeptidase to lymphocyte count ratio in predicting prognosis of patients with oral cancer: A prospective cohort study in Southeastern China.
    Head Neck. 2023 Mar 7. doi: 10.1002/hed.27331.
    >> Share

  215. ATULA M, Aro K, Irjala H, Halme E, et al
    Patient and health care delays in large (class T3-T4) oral, oropharyngeal, and laryngeal carcinomas.
    Head Neck. 2023 Mar 7. doi: 10.1002/hed.27335.
    >> Share

  216. REGNERY S, Franke H, Held T, Trinh T, et al
    Tumor treating fields as novel combination partner in the multimodal treatment of head and neck cancer.
    Head Neck. 2023 Mar 5. doi: 10.1002/hed.27298.
    >> Share

  217. XU J, Yang G, An W, Wang W, et al
    Correlations between the severity of radiation-induced oral mucositis and salivary epidermal growth factor as well as inflammatory cytokines in patients with head and neck cancer.
    Head Neck. 2023 Mar 3. doi: 10.1002/hed.27313.
    >> Share

  218. BRANDS MT, Swinkels IJ, Aarts AMWM, Verbeek ALM, et al
    Value of routine follow-up in oropharyngeal squamous cell cancer patients treated with curative intent.
    Head Neck. 2023;45:586-594.
    >> Share

  219. MCDERMOTT JD, Amini A, Molina E, Stokes WA, et al
    Treatment outcomes and cost comparisons for older adults with T4 laryngeal squamous cell cancer.
    Head Neck. 2023;45:664-674.
    >> Share

  220. JANOPAUL-NAYLOR JR, Rupji M, Tobillo RA, Lorenz JW, et al
    Ninety-day mortality following transoral robotic surgery or radiation at Commission on Cancer-accredited facilities.
    Head Neck. 2023;45:658-663.
    >> Share

  221. LEE YK, Manek R, Hardman J, Ghedia R, et al
    Transoral robotic surgery in a modified Trendelenburg position for oropharyngeal squamous cell carcinoma in a patient with severe thoracic kyphosis.
    Head Neck. 2023;45:E5-E9.
    >> Share

  222. COSTANTINO A, Sampieri C, Pirola F, De Virgilio A, et al
    Development of machine learning models for the prediction of positive surgical margins in transoral robotic surgery (TORS).
    Head Neck. 2023;45:675-684.
    >> Share

  223. SARI SY, Yigit E, Yazici G, Gullu IH, et al
    Post-induction lymph node delineation in nasopharyngeal cancer: A single-center experience.
    Head Neck. 2023;45:612-619.
    >> Share

  224. QIU Z, Lin F, Wu Z, Wu T, et al
    Why subclinical involvement is prescribed the same high dose as gross tumor volume: A study on high-dose clinical target volume in intensity-modulated radiotherapy plan of nasopharyngeal carcinoma.
    Head Neck. 2023 Mar 1. doi: 10.1002/hed.27334.
    >> Share

  225. CHEN Y, Zhang Q, Lu T, Hu C, et al
    Prioritizing sufficient dose to gross tumor volume over normal tissue sparing in intensity-modulated radiotherapy treatment of T4 nasopharyngeal carcinoma.
    Head Neck. 2023 Mar 1. doi: 10.1002/hed.27315.
    >> Share

    February 2023
  226. WITEK ME, Morris CG, Alexander GS, Dontu P, et al
    Multi-institutional study of clinical outcomes of patients with head and neck cancer presenting with cN3 disease.
    Head Neck. 2023 Feb 28. doi: 10.1002/hed.27326.
    >> Share

  227. YILDIRIM HC, Kupik GE, Mustafayev TZ, Berber T, et al
    A multicenter retrospective analysis of patients with nasopharyngeal carcinoma treated in IMRT era from a nonendemic population: Turkish Society for Radiation Oncology Head and Neck Cancer Group Study (TROD 01-001).
    Head Neck. 2023 Feb 28. doi: 10.1002/hed.27333.
    >> Share

  228. FRANZESE C, Lillo S, Cozzi L, Teriaca MA, et al
    Predictive value of clinical and radiomic features for radiation therapy response in patients with lymph node-positive head and neck cancer.
    Head Neck. 2023 Feb 23. doi: 10.1002/hed.27332.
    >> Share

  229. TAKENAKA Y, Uno A, Tanaka H, Takemoto N, et al
    Distant metastasis in head and neck squamous cell carcinoma variants: A population-based study.
    Head Neck. 2023 Feb 21. doi: 10.1002/hed.27305.
    >> Share

  230. VANGELOV B, Bauer J, Moses D, Smee R, et al
    The use of the second thoracic vertebral landmark for skeletal muscle assessment and computed tomography-defined sarcopenia evaluation in patients with head and neck cancer.
    Head Neck. 2023 Feb 21. doi: 10.1002/hed.27320.
    >> Share

  231. LIAO YH, Chou WY, Chang CW, Lin MC, et al
    Chemoprevention of oral cancer: A review and future perspectives.
    Head Neck. 2023 Feb 21. doi: 10.1002/hed.27301.
    >> Share

  232. YALAMANCHALI A, Yang K, Roof L, Lopetegui-Lia N, et al
    Comparison of real-world outcomes following immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma with outcomes of randomized controlled trials.
    Head Neck. 2023 Feb 20. doi: 10.1002/hed.27302.
    >> Share

  233. BECKETT M, Gaudet M, Bourque JM, Dennis K, et al
    Equity in adjuvant radiotherapy utilization in locally advanced head and neck cancer: A SEER-data based study.
    Head Neck. 2023 Feb 16. doi: 10.1002/hed.27319.
    >> Share

  234. BHANDARI S, Wadhwa Soni B, Gupta A, Ghoshal S, et al
    Time required for prophylactic oral care in head and neck cancer patients scheduled for radiotherapy: A single center, prospective cohort study.
    Head Neck. 2023 Feb 16. doi: 10.1002/hed.27317.
    >> Share

  235. ROCK CB, Hutten RJ, Weil CR, Lloyd S, et al
    Survival outcomes for patients with T3N0M0 squamous cell carcinoma of the glottis treated with definitive radiation alone versus chemoradiation.
    Head Neck. 2023;45:431-438.
    >> Share

  236. WANG D, Liao M, Wu J, Luo W, et al
    Salvage treatments for locally recurrent nasopharyngeal cancer: Systematic review and meta-analysis.
    Head Neck. 2023;45:503-520.
    >> Share

  237. MILLER LE, Au VH, Sivarajah S, Lin DT, et al
    Rate of atypical nodal metastases in surgically treated HPV-associated oropharyngeal squamous cell carcinoma.
    Head Neck. 2023;45:409-416.
    >> Share

  238. CANTU G
    Letter to the Editor regarding "Salvage surgery in recurrent sinonasal cancers: Proposal for a prognostic model based on clinicopathologic and treatment-related parameters".
    Head Neck. 2023;45:534-536.
    >> Share

  239. MATTAVELLI D, Tomasoni M, Ferrari M, Schreiber A, et al
    Reply to Letter to the Editor regarding "Salvage surgery in recurrent sinonasal cancers: Proposal for a prognostic model based on clinicopathologic and treatment-related parameters".
    Head Neck. 2023;45:537-539.
    >> Share

  240. PATEL R, Marano G, Joseph J, Chung J, et al
    (18) F-fludeoxyglucose positron emission computed tomography ((18) F-FDG-PET/CT) versus (68) Ga-DOTATATE-PET/CT in patients with head and neck cancer: Comparisons and implications for treatment.
    Head Neck. 2023;45:347-354.
    >> Share

    January 2023
  241. SONG X, Su L, Lin Q, Liu S, et al
    Effect of nutritional status before radiotherapy on radiation-induced acute toxicities in patients with nasopharyngeal carcinoma.
    Head Neck. 2023 Jan 4. doi: 10.1002/hed.27275.
    >> Share

  242. BUNCKE M, Andersen P, Connelly C, Clayburgh D, et al
    Novel stapler-assisted technique for closure of persistent tracheoesophageal puncture fistula.
    Head Neck. 2023;45:288-293.
    >> Share

  243. CROSSLEY JR, Nelson LL, Chou J, Maxwell JH, et al
    Distant metastases in human papillomavirus-related oropharyngeal squamous cell carcinoma: Systematic review and meta-analysis.
    Head Neck. 2023;45:275-282.
    >> Share

  244. SEO S, Rooper L, Seiwert TY, Fakhry C, et al
    Spontaneous regression of an human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Head Neck. 2023;45:E1-E4.
    >> Share

  245. MATTIOLI F, Serafini E, Lo Manto A, Mularoni F, et al
    The role of adjuvant therapy in pT4N0 laryngectomized patients: Multicentric observational study.
    Head Neck. 2023;45:197-206.
    >> Share

  246. BASTERRA J, Oishi N, Alba JR, Zapater E, et al
    Microelectrodes and radiofrequency for transoral horizontal supraglottic laryngectomy in T3 tumors.
    Head Neck. 2023;45:283-287.
    >> Share

  247. AL-QURAYSHI Z, Zhu VL, Bayon R, Buchakjian MR, et al
    Presentation and outcomes of patients with clinically T1-2, N0 oropharynx squamous cell carcinoma: The interplay of primary treatment modality and human papillomavirus status.
    Head Neck. 2023;45:64-74.
    >> Share

  248. SCOTT-WITTENBORN N, D'Souza G, Aygun N, Tewari SR, et al
    Feasibility of clinical evaluation of individuals with increased risk for HPV-associated oropharynx cancer.
    Head Neck. 2023;45:95-102.
    >> Share

    December 2022
  249. WILLEMSEN ACH, Pilz W, Hoeben A, Hoebers FJP, et al
    Oropharyngeal dysphagia and cachexia: Intertwined in head and neck cancer.
    Head Neck. 2022 Dec 30. doi: 10.1002/hed.27288.
    >> Share

  250. LEONARD JA, Hayden JA, Tripuraneni PS, Maxwell JH, et al
    Malnutrition universal screening tool predicts postoperative complications following major head and neck cancer surgery.
    Head Neck. 2022 Dec 21. doi: 10.1002/hed.27273.
    >> Share

  251. FENG Y, Xu Y, Xu T, Hong H, et al
    Recommendation for imaging follow-up strategy based on time-specific disease failure for nasopharyngeal carcinoma.
    Head Neck. 2022 Dec 15. doi: 10.1002/hed.27277.
    >> Share

  252. PETRUZZI G, Di Giorgio D, Leone F, Pichi B, et al
    The T-shaped FST pharyngoplasty step-by-step closure technique.
    Head Neck. 2022;44:2943-2946.
    >> Share

  253. YIN LX, Routman DM, Day CN, Harmsen WS, et al
    Low postoperative lymphocyte count increases risk of progression in human papillomavirus associated oropharyngeal cancer.
    Head Neck. 2022;44:2760-2768.
    >> Share

  254. MOREY T, Hodge JC, Stern C, Krishnan S, et al
    Correlation between radiologic and pathologic extranodal extension in HPV-associated oropharyngeal cancer: Systematic review.
    Head Neck. 2022;44:2875-2885.
    >> Share

  255. SIDDIQ S, Stephen S, Lin D, Fox H, et al
    Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with human papillomavirus-related squamous cell cancer: Long-term results.
    Head Neck. 2022;44:2753-2759.
    >> Share

    November 2022
  256. BLAKE CL, Brown TE, Pelecanos A, Moroney LB, et al
    Enteral nutrition support and treatment toxicities in patients with head and neck cancer receiving definitive or adjuvant helical intensity-modulated radiotherapy with concurrent chemotherapy.
    Head Neck. 2022 Nov 25. doi: 10.1002/hed.27249.
    >> Share

  257. WANG Y, Zhang L, Zhang T, Jin S, et al
    Predictive effect of pretreatment nutritional risk and GLIM-defined malnutrition on the nutrition impact symptom clusters in patients with head and neck cancer undergoing radiotherapy.
    Head Neck. 2022 Nov 23. doi: 10.1002/hed.27250.
    >> Share

  258. LI W, Liu Q, Xu H, Wang H, et al
    Innovative Fudan rT staging in endoscopic surgery for recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Nov 15. doi: 10.1002/hed.27244.
    >> Share

  259. KOTEVSKI DP, Smee RI, Vajdic CM, Field M, et al
    Empirical comparison of routinely collected electronic health record data for head and neck cancer-specific survival in machine-learnt prognostic models.
    Head Neck. 2022 Nov 11. doi: 10.1002/hed.27241.
    >> Share

  260. HU X, Tian T, Zhang X, Sun Q, et al
    Neutrophil-to-lymphocyte and hypopharyngeal cancer prognosis: System review and meta-analysis.
    Head Neck. 2022 Nov 11. doi: 10.1002/hed.27246.
    >> Share

  261. GIANNITTO C, Mercante G, Ammirabile A, Cerri L, et al
    Radiomics-based machine learning for the diagnosis of lymph node metastases in patients with head and neck cancer: Systematic review.
    Head Neck. 2022 Nov 8. doi: 10.1002/hed.27239.
    >> Share

  262. YEH CF, Lee WY, Yu TH, Hsu YB, et al
    Antipsychotic drug trifluoperazine as a potential therapeutic agent against nasopharyngeal carcinoma.
    Head Neck. 2022 Nov 8. doi: 10.1002/hed.27238.
    >> Share

  263. GIRARDI FM, Wagner VP, Martins MD, Abentroth AL, et al
    Impact of AJCC 8 pT staging in cutaneous head and neck squamous cell carcinoma in a nonselected real-world patient sample.
    Head Neck. 2022 Nov 7. doi: 10.1002/hed.27233.
    >> Share

  264. DE LEO AN, Dagan R, Morris CG, Holtzman AL, et al
    Early-stage vocal cord cancer treated with hypofractionated radiotherapy to the larynx with or without concurrent chemotherapy.
    Head Neck. 2022;44:2513-2521.
    >> Share

  265. MILLER JA, Moradi F, Sundaram V, Liang R, et al
    Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:2491-2504.
    >> Share

  266. COSTANTINO A, Pace GM, Festa BM, Ferreli F, et al
    Salivary bypass tube in total laryngectomy: Systematic review and meta-analysis.
    Head Neck. 2022;44:2608-2620.
    >> Share

  267. HOEBERS F, Yu E, O'Sullivan B, Postma AA, et al
    Augmenting inter-rater concordance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma: A multicenter study.
    Head Neck. 2022;44:2361-2369.
    >> Share

  268. BAGUE S, Leon X, Terra X, Lejeune M, et al
    Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma.
    Head Neck. 2022;44:2505-2512.
    >> Share

    October 2022
  269. KIM DH, Kim SW, Hwang SH
    Efficacy of optical coherence tomography in the diagnosing of oral cancerous lesion: systematic review and meta-analysis.
    Head Neck. 2022 Oct 28. doi: 10.1002/hed.27232.
    >> Share

  270. GALIVETI CR, Kuhnell D, Biesiada J, Zhang X, et al
    Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection.
    Head Neck. 2022 Oct 22. doi: 10.1002/hed.27231.
    >> Share

  271. SYKES KJ, Gibbs H, Farrokhian N, Arthur A, et al
    POINT: Pilot randomized, controlled, preoperative intervention for nutrition trial in head and neck cancer.
    Head Neck. 2022 Oct 17. doi: 10.1002/hed.27220.
    >> Share

  272. SANSA A, Valero C, Holgado A, Vasquez R, et al
    External validation of the H-index (host index) in patients with head and neck squamous cell carcinomas.
    Head Neck. 2022 Oct 12. doi: 10.1002/hed.27224.
    >> Share

  273. CHEN R, Cai Q, Lin P, Liang F, et al
    Role of immune-inflamed phenotype in the prognosis of hypopharyngeal carcinoma following primary surgery.
    Head Neck. 2022 Oct 12. doi: 10.1002/hed.27218.
    >> Share

  274. HE Y, Li H, Wang K, Wang J, et al
    Fourteen years old as the best age cutoff to differentiate prepubertal from pubertal papillary thyroid carcinoma.
    Head Neck. 2022 Oct 6. doi: 10.1002/hed.27208.
    >> Share

  275. MAZUL AL, Chidambaram S, Zevallos JP, Massa ST, et al
    Disparities in head and neck cancer incidence and trends by race/ethnicity and sex.
    Head Neck. 2022 Oct 6. doi: 10.1002/hed.27209.
    >> Share

  276. SCHLAFSTEIN AJ, Goyal S, Amini A, Karam SD, et al
    The impact of operability status on outcomes in patients with T4 larynx cancer undergoing larynx preservation.
    Head Neck. 2022 Oct 5. doi: 10.1002/hed.27204.
    >> Share

  277. TIRELLI G, Gardenal N, Zanelli E, Borsetto D, et al
    Prevalence and prognostic impact of retropharyngeal lymph nodes metastases in oropharyngeal squamous cell carcinoma: Meta-analysis of published literature.
    Head Neck. 2022;44:2265-2276.
    >> Share

  278. HADDAD G, Hueniken K, Xu MC, Bratman S, et al
    Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancer.
    Head Neck. 2022;44:2181-2196.
    >> Share

  279. FANTINI M, Crosetti E, Pizzorni N, Sprio AE, et al
    Voice and communication after open partial horizontal laryngectomies: A cross-sectional outcome study.
    Head Neck. 2022;44:2248-2256.
    >> Share

    September 2022
  280. CAMPO F, Mazzola F, Bianchi G, Manciocco V, et al
    Partial laryngectomy for naive pT3N0 laryngeal cancer: Systematic review on oncological outcomes.
    Head Neck. 2022 Sep 30. doi: 10.1002/hed.27205.
    >> Share

  281. LIN Q, Lin S, Chen W, Chen X, et al
    Controlling Nutritional Status (CONUT) score is a prognostic marker for laryngeal cancer patients with curative resection.
    Head Neck. 2022 Sep 28. doi: 10.1002/hed.27206.
    >> Share

  282. BAO D, Zhao Y, Liu Z, Xu H, et al
    Magnetic resonance imaging-based radiomics model for predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Head Neck. 2022 Sep 26. doi: 10.1002/hed.27200.
    >> Share

  283. LEE HN, Song CM, Ji YB, Myung JK, et al
    Occult metastasis to the superficial level VI lymph nodes in papillary thyroid carcinoma.
    Head Neck. 2022 Sep 21. doi: 10.1002/hed.27191.
    >> Share

  284. ROJO RD, Ren JL, Lipe DN, Badr H, et al
    Neuropathic pain prevalence and risk factors in head and neck cancer survivors.
    Head Neck. 2022 Sep 21. doi: 10.1002/hed.27199.
    >> Share

  285. YU J, Smith J, Marwah R, Edkins O, et al
    Return to work in patients with head and neck cancer: Systematic review and meta-analysis.
    Head Neck. 2022 Sep 19. doi: 10.1002/hed.27197.
    >> Share

  286. BATCHELOR CJJ, Flukes SP
    Tracheostomy dependence following "organ preservation" (chemo)radiation protocol for laryngeal and hypopharyngeal cancers.
    Head Neck. 2022 Sep 19. doi: 10.1002/hed.27195.
    >> Share

  287. WANG Y, Yu T, Yang Z, Zhou Y, et al
    Radiomics based on magnetic resonance imaging for preoperative prediction of lymph node metastasis in head and neck cancer: Machine learning study.
    Head Neck. 2022 Sep 17. doi: 10.1002/hed.27189.
    >> Share

  288. WATSON LJ, Woodman SH, Ganderton D, Hutcheson KA, et al
    Development of the remote 100 ml water swallow test versus clinical assessment in patients with head and neck cancer: Do they agree?
    Head Neck. 2022 Sep 16. doi: 10.1002/hed.27194.
    >> Share

  289. LI R, Ye L, Zhu Y, Ding H, et al
    Induction chemotherapy of modified docetaxel, cisplatin, 5-fluorouracil for laryngeal preservation in locally advanced hypopharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:2018-2029.
    >> Share

  290. LI F, Hsueh C, Gong H, Zhu Y, et al
    The management of metastatic neck nodes following induction chemotherapy in N2/3 classification hypopharyngeal carcinoma.
    Head Neck. 2022;44:2009-2017.
    >> Share

  291. HENG Y, Xu C, Lin H, Zhu X, et al
    Recurrence risk stratification and treatment strategies of patients with stage IVa-b hypopharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:2030-2039.
    >> Share

  292. GUO Y
    Therapy of head and neck cancer in China: Introduction to the special issue.
    Head Neck. 2022;44:2007-2008.
    >> Share

  293. ZHUANG B, Xiao S, Zhang L, Wang Y, et al
    Association between body composition and survival in head and neck cancer patients undergoing radiotherapy.
    Head Neck. 2022;44:2046-2054.
    >> Share

  294. LIU Y, Xue L, Xia Z, Zhang Q, et al
    Combined taxane, platinum, and cetuximab as a first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma: Retrospective study.
    Head Neck. 2022;44:2040-2045.
    >> Share

  295. FARRIS JC, Steber CR, Black PJ, Chan MD, et al
    Intensity-modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structures.
    Head Neck. 2022 Sep 1. doi: 10.1002/hed.27176.
    >> Share

    August 2022
  296. TERAZAWA K, Ohashi T, Shibata H, Ishihara T, et al
    Immune-modified Glasgow prognostic score: A new prognostic marker for head and neck cancer.
    Head Neck. 2022 Aug 23. doi: 10.1002/hed.27170.
    >> Share

  297. CHEN KH, Jiang YT, Zhao R, Sun YC, et al
    Development and validation of prognostic nomograms in patients with ascending type of nasopharyngeal carcinoma: A retrospective study based on SEER database.
    Head Neck. 2022 Aug 20. doi: 10.1002/hed.27172.
    >> Share

  298. KONUTHULA N, Do OA, Gobillot T, Rodriguez CP, et al
    Oncologic outcomes of salvage surgery and immune checkpoint inhibitor therapy in recurrent head and neck squamous cell carcinoma: A single-institution retrospective study.
    Head Neck. 2022 Aug 5. doi: 10.1002/hed.27162.
    >> Share

  299. PAYNE K, Brooks J, Batis N, Taylor G, et al
    Characterizing the epithelial-mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma.
    Head Neck. 2022 Aug 5. doi: 10.1002/hed.27167.
    >> Share

  300. KHAIR S, Dort JC, Quan ML, Cheung WY, et al
    Validated algorithms for identifying timing of second event of oropharyngeal squamous cell carcinoma using real-world data.
    Head Neck. 2022;44:1909-1917.
    >> Share

  301. MATTAVELLI D, Tomasoni M, Ferrari M, Compagnoni A, et al
    Salvage surgery in recurrent sinonasal cancers: Proposal for a prognostic model based on clinicopathologic and treatment-related parameters.
    Head Neck. 2022;44:1857-1870.
    >> Share

  302. BICAKCI BC, Mustafayev TZ, Cetinayak O, Igdem S, et al
    Outcomes of carotid sparing intensity-modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society/TROD-01-007.
    Head Neck. 2022;44:1825-1832.
    >> Share

  303. STRAETMANS JMJAA, Stuut M, Lacko M, Hoebers F, et al
    Additional parameters to improve the prognostic value of the 8th edition of the UICC classification for human papillomavirus-related oropharyngeal tumors.
    Head Neck. 2022;44:1799-1815.
    >> Share

  304. ZARRABI KK, Galloway TJ, Flieder DB, Kumar SS, et al
    Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancer.
    Head Neck. 2022;44:E25-E30.
    >> Share

  305. WEYERS BW, Birkeland AC, Marsden MA, Tam A, et al
    Intraoperative delineation of p16+ oropharyngeal carcinoma of unknown primary origin with fluorescence lifetime imaging: Preliminary report.
    Head Neck. 2022;44:1765-1776.
    >> Share

  306. CARPENTER DJ, Hamdi OA, Finberg AM, Daniero JJ, et al
    Laryngotracheal stenosis: Mechanistic review.
    Head Neck. 2022;44:1948-1960.
    >> Share

  307. BENALI J, Viljoen G, Ayad T, Gravier-Dumonceau R, et al
    Management of oral feeding following total laryngectomy around the world: YO-IFOS international study.
    Head Neck. 2022;44:1755-1764.
    >> Share

    July 2022
  308. DORR MC, Hoesseini A, Sewnaik A, Hardillo JA, et al
    Impact of a prognostic model for overall survival on the decision-making process in a head and neck cancer multidisciplinary consultation meeting.
    Head Neck. 2022 Jul 30. doi: 10.1002/hed.27163.
    >> Share

  309. BEDDOK A, Saint-Martin C, Krhili S, Eddine CA, et al
    Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and analysis of patterns of failure.
    Head Neck. 2022 Jul 25. doi: 10.1002/hed.27153.
    >> Share

  310. WANG M, Zhuoma C, Liu X, Huang Q, et al
    Loss of exosomal miR-34c-5p in cancer-associated fibroblast for the maintenance of stem-like phenotypes of laryngeal cancer cells.
    Head Neck. 2022 Jul 22. doi: 10.1002/hed.27155.
    >> Share

  311. MARGALIT DN, Salz T, Venchiarutti R, Milley K, et al
    Interventions for head and neck cancer survivors: Systematic review.
    Head Neck. 2022 Jul 18. doi: 10.1002/hed.27142.
    >> Share

  312. WILSON T, Fleischer L, Patel S, Bhatnagar A, et al
    Outcomes of curative treatment for head and neck squamous cell carcinoma in very elderly adults >/=80 years old.
    Head Neck. 2022 Jul 13. doi: 10.1002/hed.27141.
    >> Share

  313. KIM KN, Harton J, Mitra N, Lukens JN, et al
    Acute toxicity in patients treated with concurrent chemoradiotherapy with proton versus intensity-modulated radiation therapy for nonmetastatic head and neck cancers.
    Head Neck. 2022 Jul 13. doi: 10.1002/hed.27146.
    >> Share

  314. ZHOU Y, Wang J, Huang Z, Gong P, et al
    Deriving prognostic significance from a molecular subtype model of laryngeal carcinoma.
    Head Neck. 2022 Jul 9. doi: 10.1002/hed.27137.
    >> Share

  315. LEE MY, Lee J, Stock S, Belfiglio M, et al
    Prognostic value of computed tomography scan detection of cartilage invasion in advanced laryngeal cancer treated with primary total laryngectomy.
    Head Neck. 2022 Jul 8. doi: 10.1002/hed.27133.
    >> Share

  316. LEE J, Kaht D, Ali S, Johnson S, et al
    Performance of the Neck Imaging Reporting and Data System as applied by general neuroradiologists to predict recurrence of head and neck cancers.
    Head Neck. 2022 Jul 8. doi: 10.1002/hed.27138.
    >> Share

  317. WADHAVKAR N, Jorgensen JB, Bollig CA
    Association of comorbidity score with perioperative outcomes following transoral robotic surgery: National analysis.
    Head Neck. 2022;44:1655-1664.
    >> Share

  318. FROEHLICH MH, Shih MC, Shehee L, Kompelli AR, et al
    Systematic review of neuroendocrine carcinomas of the oropharynx.
    Head Neck. 2022;44:1725-1736.
    >> Share

  319. SWIECICKI PL, Bellile E, Casper K, Chinn SB, et al
    Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor.
    Head Neck. 2022;44:1509-1519.
    >> Share

  320. SEO GT, Wein LE, Dowling EM, Khorsandi AS, et al
    A novel technique for management of stenosis of the postlaryngectomy stoma with preservation of a functional tracheoesophageal puncture following tracheal resection.
    Head Neck. 2022;44:1737-1741.
    >> Share

  321. DIAS DOMINGUES DR, Leech MM
    Exploring the impact of metabolic imaging in head and neck cancer treatment.
    Head Neck. 2022 Jul 1. doi: 10.1002/hed.27131.
    >> Share

    June 2022
  322. HO CM, Chen YH, Hsu WH, Wang WY, et al
    Comparative effectiveness and stage-shift effect of endoscopic exam among newly diagnosed oral cancer patients with different stages in Taiwan.
    Head Neck. 2022 Jun 25. doi: 10.1002/hed.27123.
    >> Share

  323. AL-QURAYSHI Z, Sullivan CB, Allison DB, Buchakjian MR, et al
    Presentation and outcomes of patients with clinically T1-2, N0 parotid mucoepidermoid carcinoma: The roles of elective neck dissection and adjuvant radiotherapy.
    Head Neck. 2022 Jun 22. doi: 10.1002/hed.27128.
    >> Share

  324. DAI Y, Wang Z, Yan E, Li J, et al
    Development of a novel signature derived from single cell RNA-sequencing for preoperative prediction of lymph node metastasis in head and neck squamous cell carcinoma.
    Head Neck. 2022 Jun 21. doi: 10.1002/hed.27126.
    >> Share

  325. SHAO YF, Kim S, Cramer JD, Farhat D, et al
    African American race as a risk factor associated with a second primary lung cancer after initial primary head and neck cancer.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27107.
    >> Share

  326. COSTANTINO A, Canali L, Festa BM, Spriano G, et al
    Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma of the head and neck: Systematic review and meta-analysis.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27121.
    >> Share

  327. DENISSOFF A, Huusko T, Ventela S, Niemela S, et al
    Exposure to alcohol and overall survival in head and neck cancer: A regional cohort study.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27125.
    >> Share

  328. YANG A, Tanamal P, Tibbetts K, Sumer B, et al
    Characteristics and outcomes of young patients with laryngeal cancer: National hospital-based retrospective cohort analysis.
    Head Neck. 2022 Jun 16. doi: 10.1002/hed.27120.
    >> Share

  329. SCHAR MS, Omari TI, Woods CM, Footner LR, et al
    Pharyngeal tongue base augmentation for dysphagia therapy: A prospective case series in patients post head and neck cancer treatment.
    Head Neck. 2022 Jun 4. doi: 10.1002/hed.27104.
    >> Share

  330. CHARGI N, Breik O, Forouzanfar T, Martin T, et al
    Association of low skeletal muscle mass and systemic inflammation with surgical complications and survival after microvascular flap reconstruction in patients with head and neck cancer.
    Head Neck. 2022 Jun 2. doi: 10.1002/hed.27113.
    >> Share

  331. MAZZONI A, Cazzador D, Marioni G, Zanoletti E, et al
    Treatment of advanced squamous cell carcinoma of the external auditory canal: Critical analysis of persistent failures in diagnosis and surgery with a competing-risk model.
    Head Neck. 2022 Jun 2. doi: 10.1002/hed.27111.
    >> Share

  332. ABU-SHAMA Y, Renard S, Nguyen DT, Henrot P, et al
    Descriptive analysis of recurrences of nasal intestinal-type adenocarcinomas after radiotherapy.
    Head Neck. 2022;44:1356-1367.
    >> Share

  333. DIERCKS GR, Rastatter JC, Kazahaya K, Kamani D, et al
    Pediatric intraoperative nerve monitoring during thyroid surgery: A review from the American Head and Neck Society Endocrine Surgery Section and the International Neural Monitoring Study Group.
    Head Neck. 2022;44:1468-1480.
    >> Share

  334. DE RAVIN E, Frost AS, Mady LJ, Newman JG, et al
    Transcervical styloidectomy for Eagle syndrome.
    Head Neck. 2022;44:1492-1495.
    >> Share

  335. TSANG RK, Chan WCP, Holsinger FC, Chung JCK, et al
    Long-term results of robotic-assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Jun 1. doi: 10.1002/hed.27115.
    >> Share

    May 2022
  336. KOKSAL M, Saur L, Scafa D, Sarria G, et al
    Late toxicity-related symptoms and fraction dose affect decision regret among patients receiving adjuvant radiotherapy for head and neck cancer.
    Head Neck. 2022 May 30. doi: 10.1002/hed.27103.
    >> Share

  337. NABUURS CH, Kievit W, Leemans CR, Smit CFGM, et al
    Evaluation of subclasses for T4-classified squamous cell carcinoma of the external auditory canal.
    Head Neck. 2022 May 13. doi: 10.1002/hed.27082.
    >> Share

  338. LEE J, Lee JJB, Cha IH, Park KR, et al
    Risk factor analysis of dental implants in patients with irradiated head and neck cancer.
    Head Neck. 2022 May 12. doi: 10.1002/hed.27080.
    >> Share

  339. DESHMUKH J, Chatterjee A, Dora TK, Bose S, et al
    Recurrence pattern with respect to two different dose fractionations in patients with locally advanced head and neck cancer treated with chemoradiation using image-guided volumetric arc therapy.
    Head Neck. 2022 May 10. doi: 10.1002/hed.27075.
    >> Share

  340. KUTUK T, McAllister NC, Rzepczynski AE, Williams A, et al
    Submandibular gland transfer for the prevention of radiation-induced xerostomia in oropharyngeal cancer: Dosimetric impact in the intensity modulated radiotherapy era.
    Head Neck. 2022;44:1213-1222.
    >> Share

  341. PETRELLI F, Luciani A, Ghidini A, Cherri S, et al
    Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis.
    Head Neck. 2022;44:1255-1266.
    >> Share

  342. MULLER RG, Weidenbecher M, Ludlow D
    PET/CT versus triple endoscopy in initial workup of HPV+ oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1164-1171.
    >> Share

  343. STEPAN K, Craig E, Skillington SA, Deutsch BC, et al
    Development of second primary malignancies after transoral surgery in human papilloma virus-positive oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1069-1078.
    >> Share

  344. STEVENS MN, Gallant JN, Feldman MJ, Sermarini AJ, et al
    Management of postradiation late hemorrhage following treatment for HPV-positive oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1079-1085.
    >> Share

    April 2022
  345. FORMAN R, Deshpande H, Burtness B, Bhatia AK, et al
    Efficacy and toxicity of weekly paclitaxel, carboplatin, and cetuximab as induction chemotherapy or in cases of metastases or relapse for head and neck cancer with a focus on elderly or frail patients.
    Head Neck. 2022 Apr 30. doi: 10.1002/hed.27077.
    >> Share

  346. KOBAYASHI K, Ikeda A, Matsumoto Y, Matsumura S, et al
    Surgical technique for superselective neck dissection under local anesthesia in recurrent head and neck cancer.
    Head Neck. 2022 Apr 26. doi: 10.1002/hed.27071.
    >> Share

  347. LI D, Li X, Fan G, Bian G, et al
    Identification of the regulatory role of the circ_0004788/miR-515-5p/FGF2 network in nasopharyngeal carcinoma development.
    Head Neck. 2022 Apr 23. doi: 10.1002/hed.27066.
    >> Share

  348. EARNEST-NOBLE LB, Lipsky RS, Kuhel WI, Kutler DI, et al
    Identification of occult metastatic disease via lymphoscintigraphy-guided neck dissection in N0 oral squamous cell carcinoma.
    Head Neck. 2022 Apr 16. doi: 10.1002/hed.27059.
    >> Share

  349. MUKHERJEE A, Wiener HW, Griffin RL, Lenneman C, et al
    Racial and rural-urban disparities in cardiovascular risk factors among patients with head and neck cancer in a clinical cohort.
    Head Neck. 2022 Apr 9. doi: 10.1002/hed.27054.
    >> Share

  350. ZHANG W, Li L, Guo E, Zhou H, et al
    Inhibition of PDK1 enhances radiosensitivity and reverses epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Head Neck. 2022 Apr 8. doi: 10.1002/hed.27053.
    >> Share

  351. KORPICS MC, Turchan WT, Koshy M, Spiotto MT, et al
    Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis.
    Head Neck. 2022 Apr 7. doi: 10.1002/hed.27050.
    >> Share

  352. MAO M, Qiu K, Ren J, Zhao Y, et al
    The revised Pittsburgh staging system for middle ear squamous cell carcinoma: A challenging clinical dilemma.
    Head Neck. 2022 Apr 5. doi: 10.1002/hed.27047.
    >> Share

  353. JIN YN, Liu BQ, Peng KW, Ou XQ, et al
    The prognostic value of adding systemic inflammation response index to Epstein-Barr virus DNA in childhood nasopharyngeal carcinoma: A real-world study.
    Head Neck. 2022 Apr 4. doi: 10.1002/hed.27033.
    >> Share

  354. BIRKENBEUEL JL, Pang JC, Lee A, Nguyen ES, et al
    Long-term outcomes in sinonasal squamous cell carcinoma arising from inverted papilloma: Systematic review.
    Head Neck. 2022;44:1014-1029.
    >> Share

  355. LEE HI, Kim JH, Lee JH, Wu HG, et al
    Reducing target volume in definitive radiotherapy for human papillomavirus-associated tonsil cancer.
    Head Neck. 2022;44:989-997.
    >> Share

  356. AGGARWAL P, Hutcheson KA, Goepfert RP, Garden AS, et al
    Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors.
    Head Neck. 2022;44:952-963.
    >> Share

  357. ADILBAY D, Valero C, Fitzgerald C, Yuan A, et al
    Outcomes in surgical management of sinonasal malignancy-A single comprehensive cancer center experience.
    Head Neck. 2022;44:933-942.
    >> Share

  358. YANG B, Eliot M, McClean MD, Waterboer T, et al
    DNA methylation-derived systemic inflammation indices and their association with oropharyngeal cancer risk and survival.
    Head Neck. 2022;44:904-913.
    >> Share

  359. WU SS, Chen B, Fleming CW, Shah AA, et al
    Nasopharyngeal cancer: Incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institution.
    Head Neck. 2022;44:851-861.
    >> Share

  360. BOLLIG CA, Morris B, Stubbs VC
    Transoral robotic surgery with neck dissection versus nonsurgical treatment in stage I and II human papillomavirus-negative oropharyngeal cancer.
    Head Neck. 2022 Apr 1. doi: 10.1002/hed.27045.
    >> Share

  361. TWU CW, Lin PJ, Tsou HH, Liu YC, et al
    Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Apr 1. doi: 10.1002/hed.27044.
    >> Share

    March 2022
  362. ARBAB M, Chen YH, Tishler RB, Gunasti L, et al
    Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers.
    Head Neck. 2022 Mar 31. doi: 10.1002/hed.27031.
    >> Share

  363. GETZ KR, Bellile E, Zarins KR, Chinn SB, et al
    The association between inflammatory biomarkers and statin use among patients with head and neck squamous cell carcinoma.
    Head Neck. 2022 Mar 25. doi: 10.1002/hed.27040.
    >> Share

  364. FOLEY J, Burns CL, Ward EC, Nund RL, et al
    Post-acute health care needs of people with head and neck cancer: Mapping health care services, experiences, and the impact of rurality.
    Head Neck. 2022 Mar 23. doi: 10.1002/hed.27037.
    >> Share

  365. GILLEY DR, Clark AD, Wieser ME, Bollig CA, et al
    Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution.
    Head Neck. 2022 Mar 22. doi: 10.1002/hed.27035.
    >> Share

  366. ZENGA J, Awan MJ, Frei A, Petrie E, et al
    Chronic stress promotes an immunologic inflammatory state and head and neck cancer growth in a humanized murine model.
    Head Neck. 2022 Mar 8. doi: 10.1002/hed.27028.
    >> Share

  367. AL-QURAYSHI Z, Ngouajio AL, Buchakjian MR
    Presentation and outcomes of patients with clinically T1-2, N0 supraglottic squamous cell carcinoma: The role of definitive radiotherapy compared to primary partial laryngectomy.
    Head Neck. 2022;44:735-744.
    >> Share

  368. FENLON JB, Hutten RJ, Weil CR, Lloyd S, et al
    Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins.
    Head Neck. 2022;44:606-614.
    >> Share

  369. HU JQ, Yu PC, Tan LC, Wei WJ, et al
    A novel method to reconstruct right recurrent laryngeal nerve by transforming into nonrecurrent laryngeal nerve: The end-to-free vagal laryngeal branch end anastomosis.
    Head Neck. 2022;44:805-809.
    >> Share

    February 2022
  370. MICHMERHUIZEN NL, Ludwig ML, Birkeland AC, Nimmagadda S, et al
    Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27018.
    >> Share

  371. ALZAHRANI F, Sahovaler A, Mundi N, Rammal A, et al
    Transoral robotic surgery for the identification of unknown primary head and neck squamous cell carcinomas: Its effect on the wait and the weight.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27023.
    >> Share

  372. SCHACHTEL MJC, Gandhi M, Bowman JJ, Porceddu SV, et al
    Facial nerve perineural spread from cutaneous squamous cell carcinoma of the head and neck: A single institution analysis of epidemiology, treatment, survival outcomes, and prognostic factors.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27017.
    >> Share

  373. JIANG YT, Chen KH, Yang J, Liang ZG, et al
    Prognostic significance of wait time for radical radiotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 26. doi: 10.1002/hed.27011.
    >> Share

  374. JIANG YT, Chen KH, Liang ZG, Yang J, et al
    A nomogram based on tumor response to induction chemotherapy may predict survival in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 25. doi: 10.1002/hed.27020.
    >> Share

  375. KIM HAJ, Zeng PYF, Sorgini A, Shaikh MH, et al
    Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer.
    Head Neck. 2022 Feb 21. doi: 10.1002/hed.27007.
    >> Share

  376. WENG JJ, Wei JZ, Li M, Ning LP, et al
    Prognostic value of hypothyroidism in patients undergoing intensity-modulated radiation therapy for nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 16. doi: 10.1002/hed.27006.
    >> Share

  377. LIN W, Cao D, Dong A, Liang S, et al
    Systematic construction and external validation of an immune-related prognostic model for nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 15. doi: 10.1002/hed.26996.
    >> Share

  378. NIGHTINGALE J, Gandhi M, Helena J, Bowman J, et al
    Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: Time to rethink treatment paradigms.
    Head Neck. 2022 Feb 13. doi: 10.1002/hed.27005.
    >> Share

  379. YANG ZC, Luo MJ, Sun XS, Liu LT, et al
    Definitive radiation therapy and liver local therapy in de novo liver metastatic nasopharyngeal carcinoma: Large cohort study.
    Head Neck. 2022 Feb 10. doi: 10.1002/hed.26999.
    >> Share

  380. TAKENAKA Y, Oya R, Takemoto N, Inohara H, et al
    Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta-analysis.
    Head Neck. 2022 Feb 10. doi: 10.1002/hed.26997.
    >> Share

  381. VANGELOV B, Bauer J, Moses D, Smee R, et al
    The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
    Head Neck. 2022 Feb 9. doi: 10.1002/hed.27000.
    >> Share

  382. BARRETTE LX, De Ravin E, Carey RM, Mady LJ, et al
    Reconstruction following transoral robotic surgery for head and neck cancer: Systematic review.
    Head Neck. 2022 Feb 9. doi: 10.1002/hed.26998.
    >> Share

  383. STEPHEN SE, Murphy JM, Beyer FR, Sellstrom D, et al
    Early postoperative functional outcomes following transoral surgery for oropharyngeal cancer: A systematic review.
    Head Neck. 2022;44:530-547.
    >> Share

  384. DHERE VR, Escott CE, Tian S, Switchenko JM, et al
    The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failures.
    Head Neck. 2022;44:382-390.
    >> Share

  385. SINCLAIR CF, Buczek E, Cottril E, Angelos P, et al
    Clarifying optimal outcome measures in intermittent and continuous laryngeal neuromonitoring.
    Head Neck. 2022;44:460-471.
    >> Share

  386. WITEK ME, Woody NM, Musunuru HB, Hill PM, et al
    Defining high-risk elective contralateral neck radiation volumes for oropharynx cancer.
    Head Neck. 2022;44:317-324.
    >> Share

  387. BRIL SI, Chargi N, Pezier TF, Tijink BM, et al
    Arterial calcification on preoperative computed tomography imaging as a risk factor for pharyngocutaneous fistula formation after total laryngectomy.
    Head Neck. 2022;44:307-316.
    >> Share

    January 2022
  388. SINGH M, Thankappan K, Balasubramanian D, Pillai V, et al
    Incorporation of adverse features in advanced oral cancer improves precision in staging and patient prognostication.
    Head Neck. 2022 Jan 31. doi: 10.1002/hed.26990.
    >> Share

  389. DEUNING-SMIT E, Custers JAE, Mirosevic S, Takes RP, et al
    Prospective longitudinal study on fear of cancer recurrence in patients newly diagnosed with head and neck cancer: Course, trajectories, and associated factors.
    Head Neck. 2022 Jan 27. doi: 10.1002/hed.26985.
    >> Share

  390. HOYLE JM, Correya TA, Kenzik K, Francisco L, et al
    Factors associated with loss to follow-up after radiation therapy for head and neck cancer.
    Head Neck. 2022 Jan 25. doi: 10.1002/hed.26986.
    >> Share

  391. LIU X, Wu B, Huang J, Qin Y, et al
    Tumor factors associated with in-field failure for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Head Neck. 2022 Jan 24. doi: 10.1002/hed.26983.
    >> Share

  392. TUOMI L, Dotevall H, Bergquist H, Petersson K, et al
    The effect of the Shaker head-lift exercise on swallowing function following treatment for head and neck cancer: Results from a randomized, controlled trial with videofluoroscopic evaluation.
    Head Neck. 2022 Jan 23. doi: 10.1002/hed.26982.
    >> Share

  393. GAO P, Peng W, Hu Y
    Prognostic and clinicopathological significance of lymphocyte-to-monocyte ratio in patients with nasopharyngeal carcinoma: A meta-analysis.
    Head Neck. 2022 Jan 20. doi: 10.1002/hed.26952.
    >> Share

  394. EMERSON MA, Farquhar DR, Lenze NR, Sheth S, et al
    Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patients.
    Head Neck. 2022 Jan 19. doi: 10.1002/hed.26977.
    >> Share

  395. MASCARELLA MA, Patel T, Vendra V, Gardiner L, et al
    Poor treatment tolerance in head and neck cancer patients with low muscle mass.
    Head Neck. 2022 Jan 12. doi: 10.1002/hed.26978.
    >> Share

  396. MEULEMANS J, Vanermen M, Goeleven A, Clement P, et al
    Transoral robotic surgery (TORS) using the da Vinci Xi: prospective analysis of feasibility, safety, and outcomes.
    Head Neck. 2022;44:143-157.
    >> Share

  397. WOISARD V, Balaguer M, Fredouille C, Farinas J, et al
    Construction of an automatic score for the evaluation of speech disorders among patients treated for a cancer of the oral cavity or the oropharynx: The Carcinologic Speech Severity Index.
    Head Neck. 2022;44:71-88.
    >> Share

  398. BIGELOW EO, Harris J, Fakhry C, Gillison ML, et al
    Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522.
    Head Neck. 2022;44:158-167.
    >> Share

  399. YANG ZC, Du CC, Liu T, Liu LT, et al
    Management of first-line palliative chemotherapy for post-treatment metastasis after gemcitabine plus cisplatin induction chemotherapy: Gemcitabine plus cisplatin and non-gemcitabine plus cisplatin chemotherapy.
    Head Neck. 2022;44:113-121.
    >> Share

  400. TAN BKJ, Raghupathy J, Song HJJMD, Yeo BSY, et al
    Trainee participation does not adversely affect the safety of thyroid surgery: Systematic review and meta-analysis.
    Head Neck. 2022;44:262-274.
    >> Share

  401. RE M, Tomasetti M, Monaco F, Amati M, et al
    MiRNome analysis identifying miR-205 and miR-449a as biomarkers of disease progression in intestinal-type sinonasal adenocarcinoma.
    Head Neck. 2022;44:18-33.
    >> Share

    December 2021
  402. YANG L, Xue Y, Wei Z, Ren K, et al
    Local radiotherapy versus nonradiotherapy to distant lesions for metastatic nasopharyngeal carcinoma: A retrospective cohort study.
    Head Neck. 2021 Dec 27. doi: 10.1002/hed.26953.
    >> Share

  403. LANE C, Myers C, Jiang D, Cooke A, et al
    Selected functional outcomes in advanced oral cancer: Comparison of surgery alone versus surgery with postoperative radiotherapy.
    Head Neck. 2021 Dec 23. doi: 10.1002/hed.26968.
    >> Share


  404. Magnetic resonance imaging-based radiogenomics analysis for predicting prognosis and gene expression profile in advanced nasopharyngeal carcinoma.
    Head Neck. 2021 Dec 22. doi: 10.1002/hed.26947.
    >> Share

  405. MCCUSKER MG, Mehra R, Amr S, Taylor RJ, et al
    Comparison of efficacy and toxicity of chemoradiation regimens for head and neck squamous cell carcinoma primary treatment.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26965.
    >> Share

  406. LI W, Xu R, Zhu B, Wang H, et al
    Circular RNAs: Functions and mechanisms in nasopharyngeal carcinoma.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26962.
    >> Share

  407. ROSAS RR, Nachbor KM, Handley N, Mathison G, et al
    Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26959.
    >> Share

  408. KIM MS, Malik NH, Chen H, Poon I, et al
    Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: Systematic review.
    Head Neck. 2021 Dec 19. doi: 10.1002/hed.26948.
    >> Share

  409. SUN Y, Pan H, He Y, Hu C, et al
    Functional roles of the SHCBP1 and KIF23 interaction in modulating the cell-cycle and cisplatin resistance of head and neck squamous cell carcinoma.
    Head Neck. 2021 Dec 17. doi: 10.1002/hed.26961.
    >> Share

  410. HAN SH, Cho D, Mohammad R, Jung YH, et al
    Use of the comprehensive geriatric assessment for the prediction of postoperative complications in elderly patients with head and neck cancer.
    Head Neck. 2021 Dec 17. doi: 10.1002/hed.26958.
    >> Share

  411. LERE-CHEVALEYRE A, Bernadach M, Lambert C, Cassagne L, et al
    Toxicity of induction chemotherapy in head and neck cancer: The central role of skeletal muscle mass.
    Head Neck. 2021 Dec 16. doi: 10.1002/hed.26954.
    >> Share

  412. SHEHAN JN, Alwani T, LeClair J, Mahoney TF, et al
    Social determinants of health and treatment decisions in head and neck cancer.
    Head Neck. 2021 Dec 10. doi: 10.1002/hed.26931.
    >> Share

  413. LIU T, Dai S, Zhang H, Zhong X, et al
    The best choice of induction chemotherapy for patients with locally advanced nasopharyngeal carcinoma: Bayesian network meta-analysis.
    Head Neck. 2021 Dec 4. doi: 10.1002/hed.26932.
    >> Share

  414. YAN F, Lao WP, Nguyen SA, Sharma AK, et al
    Elective neck dissection in salivary gland malignancies: Systematic review and meta-analysis.
    Head Neck. 2021 Dec 4. doi: 10.1002/hed.26923.
    >> Share

  415. JEANS EB, Shiraishi S, Manzar G, Morris LK, et al
    An comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.
    Head Neck. 2021 Dec 3. doi: 10.1002/hed.26937.
    >> Share

  416. CHOI HW, Ji YB, Kim E, Kim KN, et al
    Success rate and learning curve of intraoperative neural monitoring of the external branch of the superior laryngeal nerve in thyroidectomy.
    Head Neck. 2021;43:3946-3954.
    >> Share

  417. MEHTA MP, Prince R, Butt Z, Maxwell BE, et al
    Evaluating dysphagia and xerostomia outcomes following transoral robotic surgery for patients with oropharyngeal cancer.
    Head Neck. 2021;43:3955-3965.
    >> Share

  418. RYBKIN A, Kang JJ, Lee A, Kitpanit S, et al
    The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancers.
    Head Neck. 2021;43:3796-3809.
    >> Share

  419. BERG M, Adnan A, Hogmo A, Sjodin H, et al
    A national study of health-related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma.
    Head Neck. 2021;43:3843-3856.
    >> Share

  420. SOUSA LG, Lazar Neto F, Torman DK, Diaz EM, et al
    Therapeutic approaches and outcomes in patients with larynx or hypopharynx high-grade neuroendocrine carcinoma: A single-center retrospective analysis.
    Head Neck. 2021;43:3788-3795.
    >> Share

  421. NEWTON E, Valenzuela D, Foley J, Thamboo A, et al
    Outcomes for the treatment of locoregional recurrent nasopharyngeal cancer: Systematic review and pooled analysis.
    Head Neck. 2021;43:3979-3995.
    >> Share

  422. KU D, Hui M, Cheung P, Chow O, et al
    Meta-analysis on continuous nerve monitoring in thyroidectomies.
    Head Neck. 2021;43:3966-3978.
    >> Share

    November 2021
  423. RAVIKUMAR S, Casellas NJ, Shah S, Rieth K, et al
    Geographic disparities in head and neck cancer survival in Upstate New York 2011-2019.
    Head Neck. 2021 Nov 29. doi: 10.1002/hed.26945.
    >> Share

  424. FENG X, Zhang T, Chou J, Liu L, et al
    Comprehensive gene cluster analysis of head and neck squamous cell carcinoma TCGA RNA-seq data defines B cell immunity-related genes as a robust survival predictor.
    Head Neck. 2021 Nov 29. doi: 10.1002/hed.26944.
    >> Share

  425. AMIN N, Maroun CA, El Asmar M, Alkhatib HH, et al
    Neoadjuvant immunotherapy prior to surgery for mucosal head and neck squamous cell carcinoma: Systematic review.
    Head Neck. 2021 Nov 26. doi: 10.1002/hed.26935.
    >> Share

  426. LI G, Xia YF, Huang YX, Okat D, et al
    Intensity-modulated proton radiation therapy as a radical treatment modality for nasopharyngeal carcinoma in China: A cost-effectiveness analysis.
    Head Neck. 2021 Nov 26. doi: 10.1002/hed.26941.
    >> Share

  427. CHARTERS E, Bogaardt H, Clark J, Milross C, et al
    Functional swallowing outcomes related to radiation exposure to dysphagia and aspiration-related structures in patients with head and neck cancer undergoing definitive and postoperative intensity-modulated radiotherapy.
    Head Neck. 2021 Nov 22. doi: 10.1002/hed.26936.
    >> Share

  428. PIAI V, Jansen F, Dahlslatt K, Verdonck-de Leeuw IM, et al
    Prevalence of neurocognitive and perceived speech deficits in patients with head and neck cancer before treatment: Associations with demographic, behavioral, and disease-related factors.
    Head Neck. 2021 Nov 19. doi: 10.1002/hed.26930.
    >> Share

  429. LENZE NR, Bensen JT, Farnan L, Sheth S, et al
    Association of self-reported financial burden with quality of life and oncologic outcomes in head and neck cancer.
    Head Neck. 2021 Nov 18. doi: 10.1002/hed.26934.
    >> Share

  430. WU EL, Peesay T, Randall JA, Nelson LL, et al
    Increased body mass index predicts prolonged survival in patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26922.
    >> Share

  431. DIAO K, Wang H, Phan J
    Reply to Letter to the Editor regarding 'Stereotactic radiotherapy for reirradiation of head and neck cancer: Dosimetric details matter'.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26920.
    >> Share

  432. WEST N, Kelly C, Kovarik J, Iqbal MS, et al
    Stereotactic radiotherapy for reirradiation of head and neck cancer: Dosimetric details matter.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26925.
    >> Share

  433. IOCCA O, Copelli C, Ramieri G, Zocchi J, et al
    Antibiotic prophylaxis in head and neck cancer surgery: Systematic review and Bayesian network meta-analysis.
    Head Neck. 2021 Nov 6. doi: 10.1002/hed.26908.
    >> Share

  434. JING Z, Guo S, Li Y, Liang Z, et al
    FOXC2/ADAM12-dependent radiosensitivity of head and neck squamous cell carcinoma cells.
    Head Neck. 2021 Nov 3. doi: 10.1002/hed.26918.
    >> Share

  435. BULBUL MG, Genovese TJ, Hagan K, Rege S, et al
    Salvage surgery for recurrent squamous cell carcinoma of the head and neck: Systematic review and meta-analysis.
    Head Neck. 2021 Nov 3. doi: 10.1002/hed.26898.
    >> Share

  436. SICHERO L, Tagliabue M, Mota G, Ferreira S, et al
    Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status.
    Head Neck. 2021 Nov 2. doi: 10.1002/hed.26912.
    >> Share

  437. MIRZA FA, Johnson CZ, Byrd JK, Albergotti WG 3rd, et al
    Treatment trends for advanced oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
    Head Neck. 2021;43:3476-3492.
    >> Share

  438. FANTINI M, Crosetti E, Affaniti R, Sprio AE, et al
    Preoperative prognostic factors for functional and clinical outcomes after open partial horizontal laryngectomies.
    Head Neck. 2021;43:3459-3467.
    >> Share

  439. AMINI A, Morgan R, Meyer E, Fakhoury K, et al
    Outcomes between intensity-modulated radiation therapy versus 3D-conformal in early stage glottic cancer.
    Head Neck. 2021;43:3393-3403.
    >> Share

  440. SOLIMENO LS, Park YM, Lim JY, Koh YW, et al
    Treatment outcomes of neoadjuvant chemotherapy and transoral robotic surgery in locoregionally advanced laryngopharyngeal carcinoma.
    Head Neck. 2021;43:3429-3436.
    >> Share

  441. OBERSTE M, Riders A, Abbaspour B, Kerschke L, et al
    Improvement of patient stratification in human papilloma virus-associated oropharyngeal squamous cell carcinoma by defining a multivariable risk score.
    Head Neck. 2021;43:3314-3323.
    >> Share

  442. SMITH DH, Raslan S, Samuels MA, Iglesias T, et al
    Current salivary biomarkers for detection of human papilloma virus-induced oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:3618-3630.
    >> Share

  443. DAY AT, Yang AM, Tanamal P, Blackwell JM, et al
    Extracapsular extension, pathologic node status, and adjuvant treatment in primary surgery patients with human papillomavirus-mediated oropharyngeal cancer: National hospital-based retrospective cohort analysis.
    Head Neck. 2021;43:3345-3363.
    >> Share

  444. QUAN DL, Sukari A, Nagasaka M, Kim H, et al
    Gastrostomy tube dependence and patient-reported quality of life outcomes based on type of treatment for human papillomavirus-associated oropharyngeal cancer: Systematic review and meta-analysis.
    Head Neck. 2021;43:3681-3696.
    >> Share

  445. ZAKRZEWSKI M, Gannon OM, Panizza BJ, Saunders NA, et al
    Human papillomavirus infection and tumor microenvironment are associated with the microbiota in patients with oropharyngeal cancers-pilot study.
    Head Neck. 2021;43:3324-3330.
    >> Share

  446. ANAKAPU K, Wilson M, Findlay M, Brown T, et al
    Nutritional outcomes in patients undergoing transoral robotic surgery for head and neck cancers compared to conventional open surgery. A systematic review.
    Head Neck. 2021 Nov 1. doi: 10.1002/hed.26913.
    >> Share

    October 2021
  447. BRIL SI, Al-Mamgani A, Chargi N, Remeijer P, et al
    The association of pretreatment low skeletal muscle mass with chemotherapy dose-limiting toxicity in patients with head and neck cancer undergoing primary chemoradiotherapy with high-dose cisplatin.
    Head Neck. 2021 Oct 29. doi: 10.1002/hed.26919.
    >> Share

  448. SULTANIA M, Imaduddin M, S V Deo S, Kar M, et al
    Role of metronomic therapy for advanced oral cancers and predictors of response: A multi-institutional feasibility study.
    Head Neck. 2021 Oct 28. doi: 10.1002/hed.26904.
    >> Share

  449. ZHOU C, Cao H, Meng X, Zhang Q, et al
    Lnc-MEG3 inhibits invasion, migration, and epithelial- mesenchymal transition of nasopharyngeal carcinoma cells by regulating sequestosome 1.
    Head Neck. 2021 Oct 27. doi: 10.1002/hed.26917.
    >> Share

  450. NALLANI R, Smith JB, Penn JP, Bur AM, et al
    Decision regret 3 and 6 months after treatment for head and neck cancer: An observational study of associations with clinicodemographics, anxiety, and quality of life.
    Head Neck. 2021 Oct 27. doi: 10.1002/hed.26911.
    >> Share

  451. CHINTALA S, Quist KM, Gonzalez-DeWhitt PA, Katzenellenbogen RA, et al
    High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas.
    Head Neck. 2021 Oct 25. doi: 10.1002/hed.26906.
    >> Share

  452. LIU LT, Liang YJ, Guo SS, Xie Y, et al
    Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: A study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein-Barr virus DNA.
    Head Neck. 2021 Oct 12. doi: 10.1002/hed.26897.
    >> Share

  453. AMR S, Ioffe D, Suzuki I, Mehra R, et al
    Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Oct 10. doi: 10.1002/hed.26893.
    >> Share

  454. COGNETTI DM, Johnson JM, Curry JM, Kochuparambil ST, et al
    Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.
    Head Neck. 2021 Oct 9. doi: 10.1002/hed.26885.
    >> Share

  455. LOU DI, Dietrich MS, Deng J, Murphy BA, et al
    Mechanisms of pain and their manifestations in head and neck cancer: Importance of classifying pain subtypes.
    Head Neck. 2021 Oct 7. doi: 10.1002/hed.26859.
    >> Share

  456. LARSEN MHH, Scott SI, Channir HI, Madsen AKO, et al
    Days alive and out of hospital following transoral robotic surgery: Cohort study of 262 patients with head and neck cancer.
    Head Neck. 2021 Oct 3. doi: 10.1002/hed.26880.
    >> Share

  457. HOLCOMB AJ, Richmon JD
    Surgical margins in a single-modality transoral robotic surgery: A conundrum-Reply.
    Head Neck. 2021;43:3219-3221.
    >> Share

  458. SHAH SB, Malik A
    Surgical margins in a single modality transoral robotic surgery-A conundrum.
    Head Neck. 2021;43:3217-3218.
    >> Share

  459. BASTERRA J, Oishi N, Lopez I, Otero M, et al
    Use of monopolar microelectrodes and radiofrequency in the treatment of arytenoid edema after partial horizontal laryngectomy and radiotherapy.
    Head Neck. 2021;43:3245-3248.
    >> Share

  460. WINDON MJ, Fakhry C, Margalit DN, Dey T, et al
    Epidemiologic distinctions between base of tongue and tonsil oropharyngeal carcinomas.
    Head Neck. 2021;43:3076-3085.
    >> Share

  461. UEHARA T, Doi H, Ishikawa K, Inada M, et al
    Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: Retrospective study on predictive factors.
    Head Neck. 2021;43:3132-3141.
    >> Share

  462. SHUKLA N, Ma Y, Megwalu UC
    The role of insurance status as a mediator of racial disparities in oropharyngeal cancer outcomes.
    Head Neck. 2021;43:3116-3124.
    >> Share

  463. SUN L, Shimunov D, Tan EX, Swisher-Mcclure S, et al
    Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgery.
    Head Neck. 2021;43:3053-3061.
    >> Share

  464. ROWE LM, Connor NP, Russell JA
    Respiratory-swallow coordination in a rat model of chemoradiation.
    Head Neck. 2021;43:2954-2966.
    >> Share

  465. MENDELSOHN AH, Lawson G
    Single-port transoral robotic surgery hypopharyngectomy.
    Head Neck. 2021;43:3234-3237.
    >> Share

  466. GAINO F, Gorphe P, Vander Poorten V, Holsinger FC, et al
    Preoperative predictors of difficult oropharyngeal exposure for transoral robotic surgery: The Pharyngoscore.
    Head Neck. 2021;43:3010-3021.
    >> Share

  467. LOW CM, Balakrishnan K, Smith BM, Stokken JK, et al
    Sinonasal adenocarcinoma: Population-based analysis of demographic and socioeconomic disparities.
    Head Neck. 2021;43:2946-2953.
    >> Share

  468. PARHAR HS, Weinstein GS, O'Malley BW Jr, Shimunov D, et al
    Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
    Head Neck. 2021;43:2923-2934.
    >> Share

  469. BARBON CEA, Yao CMKL, Alvarez CP, Goepfert RP, et al
    Dysphagia profiles after primary transoral robotic surgery or radiation for oropharyngeal cancer: A registry analysis.
    Head Neck. 2021;43:2883-2895.
    >> Share

  470. THAKAR A, Panda S, Kakkar A, Singh V, et al
    A matched pair analysis of oncological outcomes in human papillomavirus-negative oropharyngeal squamous cell carcinoma: Transoral surgery versus radiotherapy or concurrent chemoradiation.
    Head Neck. 2021;43:2896-2906.
    >> Share

    September 2021
  471. SANABRIA A, Pinillos P, Lira RB, Shah JP, et al
    Current therapeutic options for low-risk papillary thyroid carcinoma: A scoping evidence review.
    Head Neck. 2021 Sep 30. doi: 10.1002/hed.26883.
    >> Share

  472. VILASECA I, Aviles-Jurado FX, Valduvieco I, Berenguer J, et al
    Transoral laser microsurgery in locally advanced laryngeal cancer: Prognostic impact of anterior versus posterior compartments.
    Head Neck. 2021 Sep 27. doi: 10.1002/hed.26878.
    >> Share

  473. FENG G, Wang T, Xue F, Qi Y, et al
    Identification of enhancer RNAs for the prognosis of head and neck squamous cell carcinoma.
    Head Neck. 2021 Sep 27. doi: 10.1002/hed.26877.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016